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ABSTRACT 
 
Inflammatory bowel disease (IBD) are inflammatory disorders with multi-factorial 
etiologies and many contributing factors (e.g., genetic disposition, luminal antigen, gut 
microbiota, and environment) that occur in about 1 in 300 persons in the United States 
and other western countries, but its etiology is still not well understood. Research has 
shown that maintenance of epithelial barrier plays an important role in mucosal 
homeostasis. Intestinal epithelial cells (IECs) play a critical role in formation and 
maintenance of the intestinal epithelial barrier which functions as a protective barrier 
from microbial components, environmental pollutants, food particles, and other luminal 
content and xenobiotics. As environmental factors can contribute to the onset or 
exacerbate the effects of IBD, there are not many studies investigating the impact of 
environmental factors, more specifically metal oxide nanoparticles found in the 
environment and food products, on the maintenance of the intestinal epithelial barrier. 
Furthermore, there are no studies investigating the impact of metal oxide nanoparticles 
in combination with microbial components or host inflammatory mediators on the health 
of intestinal epithelial cells. 
 Metal oxide nanoparticles, specifically manganese oxide nanoparticles (MnO NP) 
and titanium dioxide nanoparticles (TiO2 NP), are used in everyday life in a variety of 
applications, including welding, magnetic resonance imaging, drug delivery, and food 
products. Despite the gastrointestinal (GI) tract being the major route of excretion of 
metal oxide nanoparticles, studies that assess the toxicity of these nanoparticles on 
intestinal epithelial cells (IECs) and their interaction with components of the GI tract, 
such as the microbiota and host inflammatory mediators, are virtually nonexistent.  
vi 
 
 In this research, we examine the toxicity of MnO NP in conjunction with bacterial 
lysate on IECs and TiO2 NP in conjunction with host inflammatory mediators on IECs. In 
the studies in this dissertation, MODE-K cells, mouse intestinal epithelial cells, were 
exposed to nanoparticles (10 µg/ml MnO NP or 50 µg/ml TiO2 NP) alone or 
nanoparticles plus bacterial lysate or nanoparticle plus host inflammatory mediators for 
the duration of the experiment. Taken together, data suggests that toxicological effects 
of metal oxide nanoparticles (MnO NP and TiO2 NP) on intestinal epithelial cells were 
exacerbated in the presence of presence of microbial components and host 
inflammatory mediators. 
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CHAPTER 1. GENERAL INTRODUCTION 
 
 Inflammatory bowel disease (IBD) are inflammatory disorders with multi-
factorial etiologies that occur in about 1 in 300 persons in the United States and other 
western countries, but its etiology is still not well understood. IBD describes a group of 
chronic intestinal inflammatory disorders that consist of complex interactions between 
gastrointestinal microbiota, genetics, immune system and the environment with the 
environment being the least studied of the four contributing factors. Research has 
shown that maintenance of epithelial barrier plays an important role in maintaining 
mucosal homeostasis. Intestinal epithelial cells (IECs) play a critical role in formation 
and maintenance of the intestinal epithelial barrier which functions as a protective 
barrier from microbial components, environmental pollutants, food particles, and other 
luminal content and xenobiotics. As environmental factors can contribute to the onset or 
exacerbate the effects of IBD, there are not many studies investigating the impact of 
environmental factors on the maintenance of the intestinal epithelial barrier. 
 With the increasing use of metal oxide nanoparticles in everyday life in a variety 
of applications, including welding, magnetic resonance imaging, drug delivery, and food 
products, there needs to be more studies assessing the impact of these nanoparticles 
on the intestinal epithelial barrier as the gastrointestinal (GI) tract is the major route of 
excretion of metal oxide nanoparticles. Together the research in this dissertation 
evaluates the impact of metal oxide nanoparticles in combination with microbial 
components or host inflammatory mediators on intestinal epithelial cells. By 
investigating the impact of metal oxide nanoparticles in combination with microbial 
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components and host inflammatory mediators, we are adding a level of complexity to 
the assessment of nanoparticle toxicity on intestinal epithelial cells that represents a 
more realistic representation of in vivo situation as intestinal epithelial cells do not 
interact with these nanoparticles in isolation. 
 
Dissertation Organization 
 This dissertation is composed of 5 chapters, two of which will be submitted to 
journals. After this introductory chapter, Chapter 2 is a review of the literature relevant to 
this dissertation. Chapter 3 is a manuscript that will be submitted to the journal, 
Environmental Toxicology and Pharmacology. Chapter 4 is a manuscript to be 
submitted to Food and Chemical Toxicology. This dissertation also contains a general 
conclusions and discussion chapter that discusses the conclusions from Chapters 3 and 
4 and future directions for research. This dissertation also contains an appendix that is a 
partial manuscript and it will be used as pilot data for future studies and grant proposals. 
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CHAPTER 2. LITERATURE REVIEW 
 
Inflammatory Bowel Disease (IBD) 
 An increase in the occurrence of inflammatory bowel disease (IBD), such as 
Crohn’s disease (CD) and ulcerative colitis (UC), has been observed in the western 
societies, making IBD one of the most common chronic inflammatory diseases in this 
population in recent years (1). Epidemiological studies of IBD are important because 
various epidemiological data, such as differences in occurrence between different age 
groups, geographic distribution and particularly changes in incidence over time within 
one area, can offer important insight into pathogenesis, disease associations, health 
burden, and natural history of disease (2). Therefore, epidemiologic and genetic 
research is crucial to understand the role of genetics and environmental factors in the 
development of IBD (3). As genetic changes in the population does not explain the 
increase in GI disease seen in Western societies, it is necessary to start including the 
contribution of environmental factors as they are constantly and rapidly being altered 
and incorporated in everyday life. Smoking, oral contraceptives, diet, and 
appendectomy have all been studied as environmental factors that contribute to the risk 
or onset of IBD. However, the results from these studies do not completely explain the 
prevalence or increases in the incidence of IBD (4). Many genes, such as NOD2 and 
TNFSF15, linked to IBD play critical roles in the normal function of the immune system. 
Additionally, genes such as tight junction proteins linked to epithelial integrity may play a 
role in the pathogenesis of inflammatory bowel disease as well, but this relationship is 
not well understood. One of the major pathological indicators of IBD includes an 
increased permeability of the intestinal epithelial barrier and chronic inflammation. 
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Cytokines play a critical role in the immune response and act as mediators of 
inflammation, with some being pro-inflammatory and others anti-inflammatory. In the 
inflamed intestinal mucosa, IBD patients were shown to produce elevated levels of pro-
inflammatory cytokines such as IL-1ß, IL-6, IL-8, and TNFα (5). Studies have shown that 
pro-inflammatory cytokines, including TNFα, IL-1β, and IFN-γ, cause an increase in the 
permeability of the intestinal epithelial barrier (6). The understanding of these effects in 
IBD patients will contribute to the overall knowledge of IBD and the identification of 
intervention strategies. 
 Ulcerative colitis and CD, the primary disease etiologies associated with IBD, are 
precipitated by a complex interaction between environmental, genetic, and 
immunoregulatory factors (7). Higher rates of IBD are seen in northern, industrialized 
countries, with the greater prevalence among Caucasians and Ashkenazic Jews (8-10). 
Regardless of the underlying genetic predisposition, a growing body of data implicates a 
dysfunctional mucosal immune response to resident bacteria in the pathogenesis of 
IBD, especially CD. Possible triggers include a chronic inflammatory response 
precipitated by infection with a particular pathogen or virus or a defective mucosal 
barrier (5,6). The characteristic inflammatory response results in an infiltration of 
neutrophils and macrophages, after the release of chemokines and cytokines from the 
intestinal epithelial cells. In this regard, the epithelial barrier plays an important role in 
the maintenance of mucosal immune homeostasis by controlling and preventing the 
immune response from decaying into unmanageable inflammation. There has been a 
growing body of data that have identified genes associated with defects in epithelial 
barrier function and epithelial permeability and disorders that are well recognized and 
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contribute to early onset IBD (11). A study performed in mice showed that mice deficient 
in guanylate cyclase 2C (GUCY2C-/-) exhibited intestinal barrier hyperpermeability 
associated with reduced expression of tight junction proteins. Conversely, activation of 
GUCY2C in mice reduced intestinal barrier permeability associated with increased 
expression junctional proteins (12). In an in vitro model of polymorphonuclear leukocyte 
(PMN) transepithelial migration in the intestinal mucosa of CD patients, the expression 
and regulation of ADAM17 activity was higher both in the early phase of PMN 
transepithelial migration and in active CD (13). This data indicates that genetic 
predisposition can alter the intestinal epithelial barrier and play a role in causing 
deleterious effects that can lead to the impairment of barrier function, induction of 
inflammatory cytokines and development of chronic inflammation and diseases caused 
by chronic inflammation such as IBD. 
Immune Response and Cytokines 
 Cytokines, which can be pro-inflammatory or anti-inflammatory, are small 
secreted proteins released by cells that have a specific effect on the interactions and 
communications between cells. Cytokines are involved in a variety of biological 
processes, including cell activation, replication, and differentiation, and they are central 
to the development of inflammation and immunity (5). The imbalance between pro-
inflammatory and anti-inflammatory cytokines that occurs in IBD patients impedes the 
resolution of inflammation and leads to disease perpetuation and tissue destruction (14). 
Inflammatory bowel disease, which includes CD and UC, represents a group of chronic 
disorders characterized by inflammation of the gastrointestinal tract (GIT), typically with 
a relapsing and remitting clinical course of disease. The intestinal inflammation in IBD is 
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controlled by a complex interplay of innate and adaptive immune mechanisms. 
Cytokines are key signals in the intestinal immune system, and are known to participate 
in the disruption of the so-called normal state of controlled inflammation (physiological 
inflammation of the gut) (15). Activated macrophages are thought to be major 
contributors to the production of inflammatory cytokines in the gut, and an imbalance of 
cytokines contributes to the pathogenesis of IBD (15,16). Cytokine responses are the key 
pathophysiologic elements that govern the initiation, evolution and, ultimately, the 
resolution of GI inflammation that characterize IBD. Cytokines are small peptide 
proteins produced mainly by immune cells that facilitate communication between cells, 
stimulate the proliferation of antigen specific effector cells, and mediate local and 
systemic inflammation via autocrine, paracrine, and endocrine pathways (17).  
 In IBD, the innate immune response plays a critical role. Activated dendritic cells 
(DC) and macrophages secrete cytokines that actively regulate the inflammatory 
response in UC and CD (18). Once secreted by antigen presenting cells (APC) such as 
DCs and macrophages, these cytokines activate and induce the differentiation of T cells 
that results in the activation of adaptive immunity. T cell dysregulation is often a 
characteristic of IBD associated with the failure to clear overreactive and/or autoreactive 
T cells that may result from an imbalance between Treg, Th1, Th2 and Th17 cells 
populations in the affected tissue (16). Proinflammatory cytokines are produced 
predominantly by activated macrophages and are involved in the up-regulation of 
inflammatory reactions. There is abundant evidence that certain pro-inflammatory 
cytokines such as IL-1β, TNF-α, and IL-6 are involved in the process of pathological 
pain (15,16,18,19). IL-6 has been shown to play a crucial role in several processes essential 
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to intestinal epithelial cells. The intestinal epithelial barrier is composed of intestinal 
epithelial cells which are connected by tight junction proteins, adherens junctions, gap 
junctions, and desmosomes. All these components interact and regulate intestinal 
epithelial permeability which plays an important role in regulation of gut homeostasis. In 
particular, IL-6 produced by epithelial cells and intraepithelial lymphocytes at the onset 
of mucosal injury has been shown to be crucial for epithelial cell proliferation and wound 
healing (20). Results from an in vitro study using Caco-2 cells showed that IL-6 
modulation plays a role in regulating intestinal epithelial tight junction permeability is by 
decreasing the expression of claudin-2 (21). There have also been studies in which IL-6 
is required for survival of intestinal epithelial cells and development of colitis-associated 
cancer (22). This shows that IL-6 is an important cytokine that plays a role in the function 
and response of the intestinal epithelial barrier and a major regulator of several 
functions during colonic inflammation.  
Intestinal Epithelial Barrier 
 Intestinal mucosa is composed of different types of epithelial cells with specific 
functions (Figure 1).  
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Figure 1. The intestinal epithelium and various intestinal epithelial cell types 
 
 The intestinal epithelium is populated by distinct types of cells derived from stem 
cells, such as the absorptive cells (enterocytes) and a variety of secretory cells including 
goblet cells, hormone-secreting enteroendocrine cells, Tuft cells, and antimicrobial 
peptides-secreting Paneth cells (23). All but the Paneth cells mature and differentiate as 
they migrate from the crypts to the tips of the villi in the small intestine (24,25). This 
continuous process of replication and differentiation replenishes the intestinal epithelium 
every 3-7 days and is important for the maintenance of epithelial function, integrity, and 
health (23, 26, 27). As the GIT is constantly exposed to microbes and microbial antigens, 
the intestinal epithelium must be capable of rapid regeneration in the event of tissue 
damage. Disruption of the intestinal barrier have been shown to lead to or be present in 
the early onset of several immune-mediated diseases including IBD, food allergy, and 
celiac disease (28-30). Epithelial cells control association of bacterial populations with the 
mucosal surface without disrupting the intestinal microbiota and are also capable of 
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modulating mucosal immune responses indicating their essential role in maintaining gut 
homeostasis. Consequently, the regulation of intestinal epithelial homeostasis is crucial 
for the maintenance of the structure and barrier function of the intestinal mucosa. As the 
gut mucosa is continuously facing a barrage of biological challenges including local and 
foreign antigen, environmental toxicants, and biological toxins, the intestinal epithelial 
barrier is the first line of physical defense in the intestine (Figure 2).  
 
 
Figure 2. The intestinal epithelial barrier facing biological challenges 
 
 The intestinal epithelium and its permeability is regulated by the presence of tight 
junctions (TJs), comprised of claudins, occludins, and zona occludens (ZO), which 
ultimately regulates molecule passage through the paracellular spaces (31). Factors that 
contribute to the integrity and proper function of the intestinal epithelial barrier includes, 
but are not limited to, resilient innate immune responses, intestinal epithelial cell 
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integrity, and epithelial paracellular permeability that is regulated by tight junction 
proteins (31). Intestinal epithelial cells recognize foreign and indigenous matter and 
accordingly interact with mucosal immune cells to establish and create an 
immunologically balanced mucosa eventually establishing intestinal homeostasis (32). 
Consequently, intestinal epithelial cells are at the forefront of the formation and 
continuance of a physiologically and immunologically balanced intestinal environment. 
In intestinal epithelial cells, the expression of tight junction proteins are critical to 
maintaining a healthy mucosal environment and important to an effectively functioning 
intestinal barrier (33). As some of the challenges that the intestinal epithelium faces are 
going to come from unknown influences, there will also be some advantages and 
disadvantages that will be presented by microbiota both resident and transient. For 
example, resident, non-pathogenic members of the microbiota play a role in several 
intestinal epithelial cell processes, including intestinal epithelial cell turnover, promotion 
of epithelial restitution, and reorganization of tight junction proteins (34). However, there 
are also disadvantages that can be presented by microbial products. Microbial products 
have been shown to interact with and interfere with tight junction processes, which then 
negatively affect the integrity of the intestinal epithelial barrier by compromising 
tightness of the intestinal epithelial barrier (35). HT-29 cells exposed to staphylococcal 
enterotoxin B and cholera toxin for 48 hours resulted in an increase in claudin-2 which 
resulted in increased epithelial permeability (35). As increased chronic inflammation is 
one of the main pathological indicators of IBD, there also seems to be a deleterious 
effect on the integrity of the intestinal epithelial barrier suggesting that there may be 
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polymorphism in genes linked to expression of proteins involved in maintaining intestinal 
epithelial barrier and tight junctions. 
Tight Junction Proteins 
 The intercellular junctional complex, which consists of TJs, adherens junctions, 
gap junctions, and desmosomes, is critical for the maintenance of the intestinal barrier 
(Figure 3).  
 
 
Figure 3. Intercellular junctional complexes 
 
 TJs, which are composed of claudins, occludins, and zona occludens (ZO) 
proteins, are a multifunctional complex that create a seal between adjacent epithelial 
cells near the apical surface (36). Due to interactions with external stimuli, such as food 
residues as well as pathogenic and resident bacteria, TJs are not static but are highly 
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active structures that are continuously being modified (37). They can regulate the entry of 
nutrients, ions, and water while restricting microbial entry and, thus, are the central gate 
keepers of the paracellular spaces. The intestinal epithelium consists of mainly 
absorptive enterocytes (over 80%) but also include enteroendocrine, goblet, and Paneth 
cells (38). These epithelial cells are tightly bound together by intercellular junctional 
complexes that regulate paracellular permeability and are crucial for the integrity of the 
epithelial barrier. Adherens junctions are located beneath the TJ and are involved in 
cell-cell adhesion and intracellular signaling (39). Both TJ and adherens junctions 
(together known as the apical junctional complex) are associated to the actin 
cytoskeleton (39, 40). Desmosomes and gap junctions are involved in cell-cell adhesion 
and intracellular communication, respectively (41, 42). Claudins are tetraspan 
transmembrane proteins of TJs that determine the barrier properties of cell–cell contact 
and paracellular tightness and the selective ion permeability existing between the 
plasma membranes of two neighboring cells (43). Claudins can completely tighten the 
paracellular cleft for solutes, and they can form paracellular ion pores (43, 44). 
 Claudins, specifically claudin-2 which has a pore radius of 3.25–4 angstroms (Å), 
can affect and modify the uptake of water and other solutes (44-46). Claudins are mainly 
responsible for the “pore” pathway, and the two extracellular loops work as an 
“electrostatic selective filter” to select the size and charge for small pores whereas an 
increase in the expression of pore forming claudins often leads to barrier dysfunction 
(44). Claudins play a role in forming pores that make the intestinal epithelial barrier 
permeable while they also play a role in creating seals which makes the intestinal 
barrier impermeable. Claudins 2, 7, 10, and 15 have been identified as pore forming 
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claudins while claudins 4, 5, 8, 11, and 14 selectively decrease the paracellular cation 
permeability through TJ therefore identified as seal forming claudins (44). The regulation 
of TJs is very critical to barrier maintenance and barrier dysfunction can lead to a 
change in expression of TJs and an influx of toxic agents crossing the intestinal 
epithelium resulting in tissue damage and/or inflammation with detrimental effects to gut 
homeostasis. 
 As the intestinal epithelial barrier function is an important aspect in gut 
homeostasis, there are several agents that can interfere with and affect transepithelial 
electrical resistance (TEER) and expression of TJ proteins, ultimately affecting intestinal 
epithelial barrier permeability. Included in many of these toxic agents are nanoparticles, 
such as silver nanoparticles. Using T84 cells as an in vitro model of the human GI 
epithelium, results showed that, silver nanoparticles between 10 nm and 110 nm in size 
had significant effects on intestinal permeability by altering TJ function as measured by 
a decrease in TEER (47). Without being toxic to cells, exposure to silver nanoparticles 
has been shown to significantly affected gene expression of NOTCH1 and ZO-2 which 
are involved in anchoring TJs, cellular proliferation, and signaling (47). In another study 
using both in vitro (Caco-2, human intestinal epithelial model) and in vivo (mouse) 
models, results provided direct evidence that intestinal epithelial tight junctions can be 
opened transiently and reversibly by chitosan nanoparticles that affected the trans-
membrane junctional adhesion protein (JAM-1), which directly associate with the zona 
occludens (48). Such effects have the potential to compromise the integrity of the 
intestinal epithelium and a disruption of gastrointestinal homeostasis (47).  
14 
 
 
In contrast, some nanoparticles do not possess cytotoxicity characteristics; 
however, even without the adverse cytotoxic effects on intestinal epithelial cells, 
nanoparticles can alter or downregulate the expression of TJ proteins critical for 
maintenance of the intestinal epithelial barrier (47, 48). By impairing the intestinal epithelial 
barrier, toxic agents from the lumen will be able to freely cross the epithelial barrier 
resulting in an adverse response with downstream consequences including 
inflammation and oxidative stress which can then lead to more serious health 
consequences, such as IBD and other forms of chronic disease.   
Gut Microbiota 
 Through a complex interaction with the host, gut microbiota influences several 
essential functions of the GI epithelium including functional maturation of the physical 
barrier, enhancing and maturation of the mucosal immune responses, and detoxifying 
harmful intestinal content (49-51). In addition, the gut microbiota enhances the host's 
metabolic capacity for processing nutrients and drugs and modulate multiple metabolic 
pathways in a variety of organ systems (51). Because a disruption to the balance of the 
microbiota (e.g., dysbiosis) is associated with an increased risk of developing 
inflammatory diseases, allergic diseases, and metabolic disorders, it is very important to 
understand how changes in microbiota affect GI disease conditions, facilitate the clinical 
interpretation of treatments with xenobiotics, and assess the relationship between the 
environment and disease susceptibility (52-54).   
 In vivo studies performed in germ-free mice have shown that intestinal 
inflammation and developmental aspects of the adaptive immune system are influenced 
by intestinal bacterial colonization (52, 55-57). Furthermore, there is bidirectional 
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communication between the microbiota and the host’s epithelial cells via secretion of 
quorum-sensing molecules or miRNA that may have direct effects on the epithelium (52, 
58). Microbiota plays a role in metabolizing nonabsorbed dietary carbohydrates, 
exfoliated epithelial cells, and mucus to produce metabolites, such as butyrate, that 
greatly influence intestinal epithelial energy needs and regulation of immune response 
(e.g., Treg cells) (58-60).    
Intestinal Epithelial Cells and Cell Culture Models 
 The abundance of innate and adaptive immune cells that exist together with the 
microbiota in the mammalian GIT requires barrier and regulatory mechanisms that 
maintain a balance between host–microbial interactions. This homeostasis depends on 
the diverse functions of intestinal epithelial cells (IECs) including the physical 
segregation of resident bacteria in the lumen from the host and the integration of 
microbial signals such as angionenins (61, 62). Consequently, the various types of IECs 
present in the GI epithelium are critical in mediating intestinal homeostasis that permits 
the development of an immunological environment tolerant to colonization by a diverse 
microbiota.  
 The intestinal epithelium is populated by distinct types of cells derived from stem 
cells, such as the absorptive cells (enterocytes) and the secretory cells (mucus-
secreting goblet cells, hormone-secreting enteroendocrine cells, Tuft cells, and 
antimicrobial peptides-secreting Paneth cells) (23). Enterocytes and colonocytes are the 
most abundant cell type in both small and large intestines, respectively. Their primary 
function is to absorb nutrients apically and export them basally (63). Another type of cell 
present in the intestinal epithelium is the M (membranous or microfold) cell, which are 
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critical for sampling of intestinal microbiota and for transferring pathogens across the 
epithelial barrier for and facilitate presentation of microbes to underlying lymphocytes, 
macrophages and dendritic cells (64). Another type of cell present in the intestinal 
epithelium are goblet cells, which are the most abundant secretory cells in intestinal 
epithelia. Goblet cells comprise about 10-15% of the small intestinal epithelium and up 
to 50% of the colonic epithelium and their main function is to produce and secrete 
mucus that provides the epithelial cells with protective shield against toxic luminal 
contents (63, 65). Paneth cells are another intestinal epithelial cell type located in the base 
of the crypts that produce and secrete antimicrobial peptides and proteins into the 
lumen. Paneth cells are unique in several respects compared to other secretory cells of 
the intestine (63). Paneth cells also secrete factors that help sustain and modulate the 
epithelial stem and progenitor cells that cohabitate in the crypts and rejuvenate the 
small intestinal epithelium (66). Another cell type found in the intestinal epithelium is the 
enterochromaffin cell. Enterochromaffin cells are responsible for the release of many 
hormones, mainly serotonin, that play a critical role in the regulation of intestinal motility 
(67). Enteroendocrine cells, which consists of at least 15 different subtypes and comprise 
approximately 1% of the small and large intestinal epithelium, are scattered throughout 
the mucosa as individual cells that produce and secrete multiple hormones including 
motilin and secretin which elaborately control physiological and homeostatic functions in 
the digestive tract such as GI motility and digestion (68, 69).  
 With the varying cell types present in the intestinal epithelium, there are many in 
vitro cell culture models that are used to study and assess various functions of the 
intestinal epithelium. Caco-2 cells, which are derived from a heterogenenous human 
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epithelial colorectal adenocarcinoma, are a well characterized intestinal in vitro model 
widely used to evaluate the ability of chemicals to cross the intestinal barrier and their 
transport mechanisms (70). Permeability values estimated with this model correlate well 
with human in vivo absorption data for many drugs and chemicals (70). Another cell type 
used as an in vitro model to study epithelial membrane permeability is MDCK 
(Madin−Darby canine kidney) cells. MDCK cells are used as possible tool for assessing 
the membrane permeability properties of early drug discovery compounds due to their 
absorption properties and rapid cell replication properties (71). Another cell type 
frequently used in in vitro intestinal studies are T84 cell line. The T84 colonic 
adenocarcinoma cell line, which has been used extensively as a model for studies of 
epithelial chloride secretion, also produces mucin and secretes it in culture and is used 
as a model to assess the extent to which regulatory mechanisms involved in the 
secretion of mucin from goblet cells (72). One more cell type frequently used in in vitro 
intestinal studies are HT-29 cells. HT-29 cells, which originate from a human colon 
adenocarcinoma, represent a useful model system to study epithelial differentiation in 
vitro because they are highly unpolarized and undifferentiated making them a useful to 
study the events leading to the polarization of epithelial cells in a monolayer. (73). 
Another cell line that exists that is a suitable in vitro model to study function of intestinal 
epithelial cells are MODE-K cells. MODE-K cells, which are SV40 virus transformed, are 
derived from normal small intestinal cells of mice is another cell line. MODE-K cells 
express MHC class I and/or class II molecules and retain most of the phenotypic and 
functional properties of normal enterocytes making them a suitable model for studying 
the molecular basis of epithelial cell interactions (74). 
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Nanotoxicology 
 With the introduction of the nanotechnology field and nanoparticles, 
nanoparticles possess the potential to revolutionize the biomedical field because of their 
capability to impact organs and tissues at the molecular and cellular levels. 
Nanomaterials have been promoted as a revolutionary technology for cell and tissue 
engineering, medical device development, and the encapsulation and delivery of drugs, 
vaccines, diagnostic reagents, and genes (75). However, current research is fixated on 
the therapeutic applications of nanoparticles while disregarding many of the potential 
adverse environmental impacts. For example, despite the prevalent usage and 
generation of nanoparticles, information regarding cytotoxic effects and possible health 
hazards associated with nanoparticles use is extremely limited. In fact, toxicity issues 
related to nanomaterials used in nanomedicine are often ignored (76). Thus, along with 
the development of novel nanomaterials, experts in related scientific fields are calling for 
a simultaneous assessment of the toxicological and environmental effects of 
nanoparticles as studies have shown the use of medical products containing 
nanoparticles and nanomaterials may lead to chronic health risks (75, 77, 78). Patients with 
chronic diseases, such as chronic obstructive pulmonary disease, asthma, and 
cardiovascular disease might be helped by nanomedicine but it is just such patients 
whose health is adversely affected by nanoparticles in the environment (77). This shows 
that nanoparticles possess the capability to target and penetrate the barrier of specific 
organs and cells may contribute to their associated toxicity highlighting the need for 
more studies to assess their toxicological and biological effects. 
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 Nanotechnology is a rapidly growing field that has many potential advantages in 
various fields. With the goal to improve magnetic resonance imaging and appearance of 
foods, manganese oxide nanoparticles (MnO NP) and titanium dioxide nanoparticles 
(TiO2 NP), have played in important role in advancing these fields (79-84). MnO NP is a 
better T1 contrast agent than the current contrast agent that is used to capture and 
develop images in magnetic resonance imaging (MRI) while TiO2 NP enhances the 
appearance of food products. The increasing interest in nanoparticles, such as MnO NP 
for advanced technologies and biomedical applications including MRI, drug delivery, 
and oncology, has led to great excitement about potential benefits but also concern over 
the potential for adverse human health effects (85). With the growing concerns that have 
arisen about unintentional environmental and biological effects of nanoparticles, there 
needs to be further reevaluation of the toxicity that these MnO NP may have on 
biological systems (86). For example, metal-based nanoparticles could contribute to 
adverse health conditions including concentration dependent alterations in gene 
expression and other critical physiological processes, such as mitochondrial function 
and inflammatory response, due to improper intracellular trafficking and accumulation 
(87).  
 More complete understanding of the basis of metal based nanoparticles toxicity 
is essential to elucidate the occupational, environmental, and health exposure risk-
assessments related to NP toxicity. Understanding underlying process and mechanisms 
from administration to excretion must be completely assessed before large-scale 
production and use of NPs are safely and efficiently applied in their respective field of 
medicine. Regardless of whether it is direct and intentional ingestion or administration, 
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the GIT has been shown to be a possible route of entry or excretion for some of these 
nanoparticles including MnO NPs (88, 89). However, studies that take into consideration 
the interaction between gut microbiota and environmental factors (e.g., nanoparticles) 
are extremely limited. Furthermore, disruption of the gut microbiota has been linked with 
GI conditions such as inflammatory bowel disease (90). Therefore, assessing the effects 
of nanoparticles on the intestinal epithelium in the presence of gut microbiota and 
bacterial components presents a holistic and more realistic approach to assess the 
effects of NPs on intestinal epithelial cells as dysbiosis or cytotoxic effects on intestinal 
epithelial cells caused by nanoparticles could potentially worsen GI inflammation.  
Manganese Oxide Nanoparticles 
 Manganese (Mn) is found in all organisms and has critical roles in cell survival 
and death mechanisms by regulating Mn-containing enzymes such as manganese 
superoxide dismutase (MnSOD) (91). Experimental studies using human B cells and 
human neuroblastoma cells show that excess manganese exposure leads to 
accumulation of manganese in mitochondria and cell death occurs with features of an 
apoptotic mechanism that included the activation of caspase-8 (92, 93). However, with the 
goal of aiming to improve several areas in the biomedical and environmental fields, 
manganese based nanoparticles have been studied for many various applications. 
Manganese oxide nanoparticles (MnO NP) are promising materials used as contrast 
agents for magnetic resonance imaging (MRI), drug delivery, an ionization-assisting 
reagent in mass spectroscopy, and waste water treatment (79-84, 94). In a study using 
breast cancer cells, the use of MnO NP in magnetic resonance imaging results in better 
images because they possess enhanced image signal making them better T1 contrast 
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agents than the current use of gadolinium-based nanoparticles (79-83). Furthermore, MnO 
NP have also been used for intracellular delivery of siRNA while simultaneously being 
used as a T1 contrast agent (79, 83).  However, research has shown that these MnO NP 
can negatively affect and alter functions of many organs.  
 Results from an in vivo study performed in rats that were intracerebrally injected 
with MnO NP showed negative changes in the locomotor and spatial memory abilities 
that were associated with dopaminergic neuronal impairment and inflammation (95). In a 
separate study evaluating the acute MnO NP effects on liver cells, results revealed 
increased levels of lactase dehydrogenase, an indicator of cell damage, in rat liver cells 
(96). Furthermore, an in vivo study performed in rats dosed with MnO NP for 30 days 
revealed decrease levels of antioxidant activity, damaged hepatocyte membranes, and 
protein synthesizing abnormalities in the liver (97). Deleterious effects on liver cells 
revealed by those studies suggest that MnO NP can acutely and chronically affect an 
organ with critical metabolic functions including the detoxification of various xenobiotics. 
In a different study assessing oral administration of MnO NP to rats for 28 days, it was 
shown that MnO NPs were recovered in feces showing the GI tract as a route of 
excretion. Furthermore, this study also indicated that prolonged exposure to MnO NP 
resulted in genetic damage, biochemical alterations and histological changes in the 
kidney and spleen (89). However, while this study investigated systemic effects, they did 
not investigate the effects of MnO NP on the GI tract.  
 Results from these various in vitro and in vivo studies have shown that MnO NP 
can cause deleterious effects across multiple cellular components (e.g., mitochondria), 
tissues, and organ systems including the brain, liver, kidney, and spleen. However, as 
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the GIT has been shown to be a major route of exposure for MnO NP, no study has 
assessed the effects of MnO NP on the intestinal epithelial cells, which is crucial in gut 
health and formation of the of intestinal epithelial barrier. 
Titanium Oxide Nanoparticles 
 Titanium dioxide nanoparticles (TiO2 NP) less than 100 nm in diameter are 
commonly found in many consumer food products with a ranging daily intake between 
15-37.5  mg per day for a 75 kg adult (98-100, 104). Despite being found in many food 
products consumed, little is known about the fate, toxicity, and mechanism by which 
TiO2 NP affect cellular functions of intestinal epithelial cells and the maintenance of the 
epithelial barrier. Because of novel properties offered by their small size, TiO2 NP are 
introduced in a rising number of food products (www.nanotechproject.org) as an 
authorized food colorant additive (100). However, TiO2 NP has been shown to have 
deleterious effects. TiO2 NP pretreated with digestive fluids inhibit the growth of 
undifferentiated Caco-2 cells (101). In addition, uptake of TiO2 NP by enterocytes and 
paracellular passage across intact epithelia have been demonstrated (102). This process 
occurs diffusely along the length of the GIT and total uptake may be important due to 
the large surface area of the epithelium (103). As nanoparticles can affect cellular 
components, such as the mitochondria, cellular uptake and accumulation of 
nanoparticles derived from heavy metal toxicants can cause toxicity including apoptosis. 
Reactive oxygen species (ROS) production by cells exposed to TiO2 NP has been 
evidenced and considered as the main mechanism of cellular toxicity in various cell 
types (104-106).  
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 Several studies established the consequential effects of TiO2 NP exposure on 
cells and tissues, such as ROS induction and inflammatory cytokine production (104-108). 
TiO2 NP have also been shown to be absorbed from the GIT (99,109). Results of an in vivo 
study proposed that TiO2 NP uptake across the GIT to take place via the Peyer’s 
patches, due to the high presence of TiO2 NP found in the underlying lymphoid tissues 
(99, 109, 110). TiO2 NPs could translocate across both the regular intestinal epithelium and 
through Peyer’s patches resulting in NP persistence in gut cells with the potential to 
induce chronic damage (103). In a study using Caco-2 cells and mice, consequences of 
chronic damage induced by TiO2 NP included changes in expression of genes 
necessary for cell survival, up-regulation of genes involved in inflammation, apoptosis 
and cell cycle, and with down-regulation of genes involved in energy metabolism (104). 
Understanding the effect of TiO2 NP on epithelial cells and intestinal barrier and 
absorption of these nanoparticles is essential and vital in order to fully elucidate the 
safety of orally administrated TiO2 NP (101). 
Organoids 
 Intestinal epithelial cells play a role in the maintenance the intestinal epithelial 
barrier that acts as a physical barrier between our body and exogenous substances. 
Cytotoxic environments in the GI tract can cause impairment and death of the epithelial 
cells which results in the breakdown of this barrier function which can lead to 
uncontrollable inflammation increasing the risk of developing inflammatory diseases 
such as IBD. Until recently, intestinal epithelial-damaging activities of environmental 
toxicants, drugs, and treatments could be tested only in vivo in animal models because 
of the poor survival rate of primary IECs ex vivo (111). The three-dimensional culture and 
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outgrowth of intestinal crypt stem cells into organoids have offered new possibilities to 
culture and study IECs ex vivo. Organoids represent an important bridge between 
traditional 2D cultures and in vivo mouse/human models, as they are more 
physiologically relevant than monolayer culture models and are far more amenable to 
manipulation of niche components, signaling pathways and genome editing than in vivo 
models (112). The use of stem cells has allowed researchers to intensively study the 
processes that govern embryonic development, lineage specification and tissue 
homeostasis, as well as the mechanisms that contribute to the onset and manifestation 
of disease. Furthermore, organoids can be used for modeling host–microbe interactions 
(113). It also delivers invaluable mechanistic insight into the development of stem cells 
and their niches, while providing an opportunity to monitor their differentiation into 
mature functional lineages such as enterocyte, goblet cells, and enteroendocrine cells 
(114). Organoids ultimately provide an opportunity to investigate the effects of 
environmental toxicants, drugs, and treatments on the development of the intestinal 
epithelial barrier during normal and disease conditions while incorporating a more 
holistic approach that can be manipulated to mimic the intestinal environment that 
includes host-microbial interactions. 
Mitochondrial Function in Intestinal Cells and Maintenance of Intestinal Epithelial 
Barrier 
 Intestinal epithelial cells play a critical role in formation and maintenance of the 
intestinal epithelial barrier which functions as a protective barrier from xenobiotics and 
foreign substances and function as a key regulator of intestinal homeostasis. Balanced 
and dynamic interactions among mucus layers, intestinal epithelial cells, microbiota, and 
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host immune defense is essential for the maintenance of the intestinal mucosal 
homeostasis (115, 116). The disruption in the intestinal homeostasis (e.g. excessive 
inflammation, impaired intestinal epithelial barrier) results in the defective mucus barrier 
with increased permeability that results in inflammation and injury of the intestinal 
mucosal cells (117,118). Therefore, the lining of the intestine, which is composed of 
intestinal epithelial cells, is renewed at an extraordinary rate, outpacing all other tissues 
in the vertebrate body (119). Basement membrane flow, mitotic pressure and active flow 
here have been the three general mechanisms identified in the proliferation of intestinal 
epithelial cells, renewal of the intestinal epithelial barrier, and movement of the 
epithelium (120). Disturbances in epithelial function are implicated in inflammatory and 
neoplastic diseases of the GIT. Control of intestinal epithelial stemness is crucial for 
tissue homeostasis and the mitochondrial function plays a critical role in maintaining 
intestinal epithelial stemness, which is the self-renewing capacity of the stem cells 
which are within the base of the crypt to migrate upward towards the lumen of the gut as 
they mature (121). Furthermore, mitochondrial function is a key player in maintaining the 
luminal redox status of the glutathione/glutathione disulfide (GSH/GSSG) and 
cysteine/cystine (Cys/CySS) couples, which support luminal nutrient absorption, mucus 
fluidity, and a diverse microbiota crucial for maintaining intestinal epithelial integrity (122-
124). 
Mitochondria play an important role during the interaction of gut microbiota with 
the host cell and this mitochondrial activity may be an important factor that modulates 
microbiota diversity and quality, probably due to the role of mitochondria during the 
inflammatory and immune responses (125). Mitochondria are the major source of cellular 
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reactive oxygen species (ROS) and can induce cytokine release depending on the ROS 
levels in the cell (125). Interestingly mitochondrial ROS may also be involved in the 
regulation of the gut epithelial barrier. A study performed in vitro using colonic biopsy 
samples showed that induced mitochondrial dysfunction allowing transepithelial 
movement of bacteria across the intestinal epithelial barrier (126). Furthermore, an 
example of possible mitochondria–microbiota functional interaction was shown when 
modification of mitochondrial energy metabolism in male rats, via diet, was associated 
with increased production of butyrate which have been known to be produced by gut 
microbiota (127). The health and function of the mitochondria plays a crucial role in 
intestinal epithelial cells and ultimately the function and maintenance of the intestinal 
epithelial barrier and gut homeostasis. Therefore, there is a need for studies 
investigating the effects of xenobiotics and environmental toxicants that can affect 
mitochondrial function in intestinal epithelial cells while also interrogating the role of 
microbial components in disease pathogenesis as this would be a better representation 
of the holistic interactions occurring in the intestinal environment. 
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Abstract 
Manganese oxide has been shown to cause toxicity often referred to as 
manganism and is associated with occupational-related disease symptoms (e.g., 
welders). In addition, manganese oxide nanoparticles (MnO NP) are used in a variety of 
medical applications including drug delivery and magnetic resonance imaging (MRI) to 
obtain high resolution anatomical images of tumors and gastrointestinal (GI) 
inflammation. Along with the benefits, there are adverse consequences associated with 
the use MnO NPs as previously published. Additionally, GI research has shown that 
maintenance of the epithelial barrier plays a critical role in mucosal homeostasis and 
immunity as evidenced in a number of GI disorders including inflammatory bowel 
disease, which occurs in about 1 in 300 persons worldwide. However, studies assessing 
the interactions between MnO NP, the microbiota, and host inflammatory cytokines on 
mucosal homeostasis are virtually nonexistent. Using an in vitro model of GI 
homeostasis and epithelial wound healing, we examined the adverse effects of MnO NP 
alone or in combination with a bacterial lysate derived from E. coli. We hypothesized 
that treatment with MnO NP in combination with a bacterial lysate will synergistically 
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induce adverse and deleterious effects on intestinal epithelial cells. Specifically, MODE-
K cells, a murine intestinal epithelial cell line, were exposed to MnO NP alone or in 
combination with the bacterial lysate and/or inflammatory cytokines for 12, 24, or 48 
hours depending on experimental procedure. Compared to MnO NP alone, these 
studies demonstrated that the addition of MnO NP plus bacterial lysate resulted in 1) 
exacerbated deleterious effects of MODE-K cells 2) severely inhibited cell migration and 
wound healing 3) enhanced secretion of inflammatory cytokines such as IL-6, and 4) 
induced mitochondrial dysfunction as evidenced by in mitochondrial respiration. While 
the bacterial lysate had no deleterious effect on the MODE-K cells, results 
demonstrated that there is a synergistic interaction between MnO NP and microbial 
components on intestinal epithelial cells that adversely affect epithelial integrity which 
can lead to a negative impact on mucosal homeostasis. 
Introduction 
 As the gut mucosa is continuously facing a barrage of biological challenges 
including host-derived and foreign antigen, environmental toxicants, and biological 
toxins, the intestinal epithelial barrier is the first line of physical defense in the intestine. 
The epithelial barrier plays an important role in the maintenance of mucosal immune 
homeostasis by regulating inflammation (1-4). The permeability of the intestinal 
epithelium is regulated by the presence of tight junctions (TJs) that ultimately regulate 
molecule passage through the paracellular spaces (1). Intestinal epithelial cells (IECs) 
recognize foreign and indigenous matter and accordingly interact with mucosal immune 
cells to establish and create an immunologically balanced mucosa resulting in intestinal 
homeostasis (2). Consequently, intestinal epithelial cells (IECs) are at the forefront of the 
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physiological barrier separating the host from the phlogistic components present in the 
intestinal lumen. In IECs, tight junction proteins are critical to maintaining a healthy 
mucosa and important to an effectively functioning intestinal barrier (3). As the intestinal 
barrier is constantly faced with steady insult from microbial and host influences, there 
are going to be many challenges that have to be surmounted in the maintenance of the 
intestinal epithelial integrity that can potentially affect the mucosal homeostasis. As 
some of these challenges are going to come from multiple influences, there will also be 
some advantages and disadvantages that will be presented by the gut microbiota. For 
example, commensal microbiota, that inhabit our gut, plays a role in several IEC 
processes, such as the rate of intestinal epithelial cell turnover, promotion of epithelial 
restitution, and reorganization of tight junction proteins, that are critical for maintaining a 
healthy intestinal epithelial barrier (3). However, there are also deleterious outcomes that 
can be induced by microbial products. Microbial products (e.g., enterotoxin) have been 
shown to interact and interfere with tight junction processes, which then negatively 
affect the integrity of the intestinal epithelial barrier by compromising the integrity of the 
intestinal epithelial barrier and induce antigen-related intestinal inflammation (4). As 
chronic inflammation is one of the main pathological indicators of inflammatory bowel 
disease (IBD), the intestinal epithelial barrier and tight junction proteins play a major role 
in maintaining a balance between host–microbial interactions that can affect 
susceptibility to and the pathogenesis of IBD (5). 
 Disruption of the intestinal barrier and tight junction proteins (TJs), along with 
increased levels of proinflammatory cytokines, have been shown to lead to or be 
present in the early onset of intestinal diseases and disorders including IBD (39-41). 
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During normal homeostasis, proinflammatory cytokines in a normal, healthy human are 
not a problem because cytokines are involved in a variety of biological processes, 
including cell activation, growth, differentiation, and are essential to the regulation of 
inflammation and immunity (6). However, the imbalance between pro-inflammatory and 
anti-inflammatory cytokines that occurs in IBD is what impedes the resolution of 
inflammation and maintenance of the intestinal epithelium which eventually leads to 
disease perpetuation and tissue destruction (7). 
  Inflammatory bowel disease, which includes Crohn’s disease (CD) and 
ulcerative colitis (UC), represents a group of chronic disorders characterized by 
inflammation of the gastrointestinal tract (GIT). The intestinal inflammation characteristic 
of IBD is controlled by a complex interplay between innate and adaptive immune 
mechanisms (8). Cytokines are key signals in the intestinal immune system, and are 
known to participate in the regulation of the controlled inflammation (physiological 
inflammation of the gut) (8). Various cell types have been studied to evaluate 
toxicological effects and sensitivity of the intestinal epithelium to proinflammatory 
cytokines. In a study performed using Caco-2 intestinal cells, interferon gamma (IFN-γ) 
and tumor necrosis factor-alpha (TNF-α) synergize to induce intestinal epithelial barrier 
dysfunction (9). In a different study using MODE-K intestinal epithelial cells, TNF-α 
decreased cellular respiration and increased mitochondrial dysfunction which resulted in 
apoptosis of these epithelial cells (10).  
 Inflammatory mediators, such as host cytokines like TNF-α, can induce 
production of proinflammatory cytokines in IECs. In a study performed using IEC-6 
intestinal epithelial cells, TNF-α was found to enhance both interleukin-6 (IL-6) mRNA 
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expression and protein secretion (11). IL-6 is a pleiotropic, pro-inflammatory cytokine 
which plays an important role in promoting inflammatory response in the gut and in the 
systemic circulation (7, 8). Elevated IL-6 serum levels have been detected in acute and 
chronic inflammation. Moreover, elevated IL-6 production has been associated with CD 
and UC (7). As elevated levels of localized IL-6 in the intestine may be a characteristic 
feature of active IBD, intestinal epithelial cells are one of the major cell types 
responsible for the production of IL-6 (12). Modulation of IL-6 levels in the GIT can 
undermine the integrity of the intestinal epithelial barrier by decreasing the expression of 
tight junction proteins and increasing intestinal barrier permeability (13, 14).  
Nanotechnology is a rapidly growing field that has been shown to provide many 
advantages in various areas of medicine. With the goal of aiming to improve several 
technological areas, such as drug delivery and magnetic resonance imaging, the usage 
of nanoparticles, specifically metal nanoparticles including manganese oxide-based 
nanoparticles (MnO NP), have played in important role in advancing these fields (15-20). 
The increasing interest in nanoparticles, such as MnO NP, for advanced technologies 
and biomedical applications has led to great excitement about potential benefits but also 
concern over the potential for adverse human health effects (21). With the growing 
concerns regarding the unintentional environmental and biological effects of 
nanoparticles on the GIT, there needs to be further reevaluation of the toxicity that MnO 
NP may have on biological systems (22). For example, metal-based NPs could contribute 
to adverse health conditions resulting from alterations of gene expression, dysregulation 
of physiological processes due to improper intracellular trafficking, and accumulation of 
NPs at toxic concentrations (23). More complete understanding of the basis of metal-
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based NPs toxicity is essential to elucidate the occupational, environmental, and health 
risk-assessments. Regardless of whether it is intentional or unintentional ingestion, the 
GIT has been shown to be the primary route of entry for metal nanoparticles including 
MnO NP which one can be exposed to during occupation (e.g. welding) or biomedical 
field (e.g. magnetic resonance imaging (MRI)) (24, 25). Assessing the effects of 
nanoparticles on intestinal epithelial cells in the presence of bacterial components 
presents a more holistic, realistic model of exposure when assessing the effects of MnO 
NP on gut epithelial cells as the gut microbiota can influence cellular physiology, 
metabolism, and immune function (26). However, studies that take into consideration the 
interaction between host epithelial cells, nanoparticles and microbiota are extremely 
limited. Because IECs are exposed to both microbial components as well as pro-
inflammatory cytokines in vivo, we hypothesize that the combination of these factors will 
result in more realistic evaluation of the toxicity of environmental pollutants, such as 
MnO NP. Therefore, to mimic the in vivo environment, we examine the adverse effects 
of MnO NP in conjunction with bacterial lysate on intestinal epithelial cells. Results 
indicated that the health of intestinal epithelial cells was adversely affected when they 
were exposed to a combination of MnO NP and whole cell bacterial lysate than when 
they were treated with either stimulant alone. These results indicate that it is important 
to integrate the contributions of multiple stimuli on IEC health and ultimately intestinal 
barrier integrity in order to obtain a more representative impact of metal-based 
nanoparticles on the health and homeostasis of the GIT. 
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Materials and Methods 
Chemicals 
 Manganese oxide nanoparticles (MnO NP (US Research Nanomaterials, Inc., 
Houston, TX, USA)) used in all experimental procedures were kindly provided by Dr. A. 
Kanthasamy. According to product sheet associated with this product, range of MnO NP 
that were used were under 200nm in diameter.  
Cell Culture and Treatment 
 The MODE-K intestinal epithelial cell line generated from the small intestine of a 
C3H mouse was used in all experimental procedures described below (kind gift from Dr. 
C. Elson). In this study, MODE-K cells were grown in high glucose (4.5 g/L) DMEM 
medium containing 10% FBS, 2 mM L-glutamine, 50 units of penicillin, and 50 µg/mL 
streptomycin. In general, cells were inoculated into a tissue culture plate (six to 96 well) 
depending on the experimental requirements and were cultured overnight in a 
humidified atmosphere of 5% CO2 at 37 °C. The length of each experiment and MODE-
K cell density for each experiment has been provided in the methods section for each 
experimental procedure. The four treatment groups for experimental procedures were: 
control group, 1 µg/mL bacterial lysate alone, 10 µg/mL MnO NP alone, and 10 µg/mL 
MnO NP plus 1 µg/mL bacterial lysate group. The culture medium was switched from 
high glucose medium to low glucose medium when cells were being prepared to be 
used in an assay the following day. All experiments were conducted in low glucose 
DMEM medium. Dose titration experiments were performed with the bacterial lysate and 
the MnO NPs and minimal dose (that did not affect cell viability after 24 hours) were 
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chosen in order to assess the interactions between the MnO NPs and the bacterial 
lysate. 
Preparation of Bacterial Antigen 
 An adherent invasive E. coli (AIEC) strain LF82 that has been associated with 
ileal Crohn’s disease was cultivated in BHI broth and incubated at 37 °C in an aerobic 
environment. Bacteria were harvested after overnight growth, washed with PBS, frozen, 
lyophilized, and stored at -20 °C until used. Bacterial cells were weighed and 
resuspended in sterile PBS (2 mg/mL) prior to being subjected to two freeze-thaw 
cycles, followed by sonication at 50 amps, 75 amps, and 100 amps for 30 seconds at 
each amperage. This sonication cycle was repeated three times. The lysates were 
sterilized by ultraviolet irradiation and sterility confirmed bacteriologically. With minor 
modifications, this method was used as previously described (27).  
MTS Cell Viability Assay 
 Cell viability was measured using the CellTiter 96 Aqueous Non-Radioactive Cell 
Proliferation (MTS assay kit from Promega Corporation, Madison, WI). MODE-K cells 
were inoculated into 24-well plates with 120,000 cells/mL per well one day prior to 
treatment to achieve complete monolayer. The next day, MODE-K cell monolayers were 
washed twice with low glucose DMEM before addition of the respective stimulants 
diluted in low glucose DMEM medium for 48 hours. Following treatment, 20 µL of MTS 
solution reagent mix was added to each well and incubated at 37 °C for 30 minutes. At 
the end of incubation, readings were taken at a wavelength of 490 nm and another 
reference reading for each well was taken at 670 nm to eliminate background. This 
method was previously described and adopted to fit our experimental procedure (28).  
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Cytokine Release Analysis 
 Prior to assessing cell viability, supernatants were collected from MODE-K cell 
cultures at 24 and 48 hours after addition of the MnO NP or LF82 bacterial components 
and analyzed for the presence of cytokines. A multiplex assay was used to detect the 
presence of IL-6, TNFα, and IFNγ. The cytokines in each sample were measured using 
multiplex bead analysis. Standard curves were generated using Bio-Plex Manager 
Software Version 6.0 (Bio-Rad Laboratories, Inc., Carlsbad, CA, USA) 
In vitro Wound Healing Assay 
 For one-dimensional migration assays, 300,000 MODE-K cells per well were 
suspended in DMEM (low glucose, 1.0 g/L) inoculated into 12 well plates and incubated 
at 37 °C in 5 % CO2 overnight. The next day a (+) shaped scratch (i.e., monolayer 
wound) was created in each well using a P-200 pipet tip creating a cell free gap that, in 
time, would be covered by replicating/migrating MODE-K cells. Treatments were then 
added and cells were then incubated for 24 hours. Images were taken at 0 and 24 hours 
post-wounding. The four treatment groups were: medium alone (i.e., control), 1 µg/mL 
bacterial lysate, 10 µg/mL MnO NP, and 10 µg/mL MnO NP plus 1 µg/mL bacterial 
lysate. After 24 hours, experiments were terminated. Images were taken using a 5x lens 
on an inverted microscope Leica DMi1 (Leica Microsystems, IL, US) using the software 
Leica Application Suite 4.5.0 (Leica Microsystems, IL, US) from 10 representative 
wounded areas per treatment. Images and gap spacing were then measured and 
analyzed with an automation and image analysis software Metamorph 5.0.7 (Molecular 
Devices LLC, CA, US). Gap closure was quantified by determining the mean distance of 
closure (i.e., healing) of the gap. This was done by measuring the area of the cell-free 
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space separating the two edges of the cellular monolayer at 24 hours after addition of 
the treatments, and then subtracting this value from starting value that was measured at 
the 0-hour time point. This method was previously described and adopted to fit our 
experimental procedure (29).  
Mitochondrial Superoxide Generation 
 Mitochondrial superoxide generation was measured using MitoSOXTM Red 
Mitochondrial Superoxide Indicator (Thermo Scientific). The four treatment groups were: 
medium alone, 1 µg/mL bacterial lysate, 10 µg/mL MnO NP, and the 10 µg/mL MnO NP 
plus 1 µg/mL bacterial lysate. MODE-K cells were plated in 96-well plates with 8,000 
cells/well one day prior to treatment and allowed to attach overnight. The next day cells 
were washed 2 times with low glucose DMEM medium before addition of the respective 
treatments suspended in low glucose DMEM medium for a period of 24 hours. 
Following treatment, MitoSox reagent was added to each plate well at a 1:1000 
concentration. Relative fluorescence intensity was then acquired using a microplate 
reader 24 hours post-treatment.  
Mitochondrial Respiration 
 Mitochondrial respiration was measured using a Seahorse XF24e Extracellular 
Flux analyzer (Seahorse Bioscience, North Billerica, MA). The Seahorse XF24e 
Extracellular Flux analyzer is a high-throughput instrument that yields real-time 
measurements of cellular respiration rates. In our studies, we were interested in 
assessing the effects of four treatments on mitochondrial respiration and their effects on 
oxygen consumption rates (OCR). MODE-K cells were seeded at a density of 
300,000/mL into a T-25 culture flask and incubated overnight in 5% CO2 at 37.8ºC. The 
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next day, cells were treated with respective treatments for 24 hours. Stimulated cells 
were recovered from the plates by scraping and added to the Seahorse plates using 
CellTac at 60,000 cells per well and incubated for 1 hour to allow the cells to adhere. At 
this time, the mito-stressor reagents Oligomycin (1 µM), FCCP (2 µM) and 
Rotenone/Antimycin A (0.5 µM) were loaded into the corresponding injection ports of 
the Seahorse FluxPak cartridge and placed in the Seahorse analyzer to be equilibrated. 
After equilibration, the plate containing treated cells was then placed in the Seahorse 
analyzer covered with the Flux Pak cartridge. The analyzer was then programmed to 
measure the basal OCR readouts at five specified time intervals before progressing to 
inject the mito-stressors every three cycles of measuring OCR. Measuring mitochondrial 
respiration with the Seahorse analyzer allowed the measurement of the effect of each 
treatment at the three critical stages of cellular respiration.  
Statistical Analysis 
 All statistical data analyses were performed using Prism 4.0 (GraphPad 
Software, San Diego, CA). Data were analyzed using one-way ANOVA with the Tukey 
post-test for comparing all treatment groups with that of the control. Multiple 
comparisons test was also performed to analyze differences between treatment groups. 
Differences with p < 0.05 were considered significant. All data is representative of two 
independent experiments containing six wells per treatment. 
Results 
Mitochondrial Superoxide Generation 
 The presence of reactive oxygen species (ROS) may negatively impact the 
crucial barrier function of the intestinal epithelium. Reactive oxygen species 
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are increased in the inflamed mucosa of IBD patients and may contribute to loss of 
intestinal barrier function (30). Furthermore, during inflammation oxidative stress can lead 
to the induction of cell injury and apoptosis in intestinal epithelial cells (31).  
 To assess for mitochondrial ROS, we used MitoSOX assay. After 24 hours of 
incubation with the specific treatments, measurements were taken and data was 
normalized to percent control (Figure 1). Although there was no significant difference, 
there was approximately a 15% increase in mitochondrial superoxide generation in both 
treatment groups containing MnO NP (Figure 1). This data suggests that mitochondrial 
superoxide generation in intestinal epithelial cells appears to be an effect driven by the 
presence of MnO NP. 
 
Figure 1. Mitochondrial superoxide generation was measured from MODE-K intestinal epithelial 
cells 24 hours post-treatment. Data was normalized to percent control. Data presented were 
obtained from 2 different experiments. This data suggests that mitochondrial superoxide 
generation in intestinal epithelial cells appears to have an effect driven by the presence of MnO 
NP. All data is representative of two independent experiments containing six wells per 
treatment. 
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Cytokine Release 
 Damage and impairment of the intestinal surface barrier may result in an 
increased permeability and absorption of toxic and phlogistic factors leading to 
inflammation and disequilibrium of GI epithelial homeostasis (34). This inflammatory 
response can lead to the induction of cell injury and apoptosis of intestinal epithelial 
cells (31, 34).  
 After 24 hours of incubation, supernatants were harvested from MODE-K cell 
cultures to measure total cytokine secretion. However, IL-6 was the only cytokine 
detected. A significant effect was seen between treatment groups (p < 0.05) (Figure 2a). 
Post-hoc analysis (Tukey) indicated significantly (p < 0.05) higher IL-6 production when 
the 10 µg/mL MnO NP + 1 µg/mL of bacterial lysate Treatment group was compared to 
the control group. Furthermore, analysis revealed a significant increase in IL-6 secreted 
when the 10 µg MnO NP + 1 µg/mL LF82 treatment group was compared to the 10 
µg/mL MnO NP alone treatment. Compared to NP or bacterial lysate alone, the results 
revealed a synergistic IL-6 release when MnO NP was combined with the E. coli 
bacterial lysate. Similar results were also seen after 48 hours of incubation (Figure 2b). 
Further comparison between the 24 hours and 48 hours samples revealed a threefold 
increase in the 10 µg/mL MnO NP + 1 µg bacterial lysate group suggesting that Mode-K 
intestinal epithelial cells were even more affected after extended exposure. 
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Figure 2A. Supernatants from each well were taken at 24 hours post-treatment and individually 
measured for IL-6 cytokine release from MODE-K intestinal epithelial cells. 
 
 
 
Figure 2B. Supernatants from each well were taken at 48 hours post-treatment and individually 
measured for IL-6 cytokine.  IL-6 levels showed at three fold increase at 48 hour time point. All 
data is representative of two independent experiments containing six replicates per treatment. 
Different letter denotes difference in significant (p < 0.05) change. 
B 
A A 
C 
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Wound Healing 
 Wound healing is a crucial function of the intestinal epithelium as it can be injured 
by toxic luminal substances, inflammation, interactions with microbes, oxidative stress, 
and pharmaceuticals (30, 32). Upon injury, the intestinal epithelium undergoes a wound 
healing process which is dependent on the balance of three cellular events; restitution, 
proliferation, and differentiation of immature epithelial cells adjacent to the wounded 
area (33). Therefore, using a scratch wound assay, the effects of MnO NP on the wound 
healing process of MODE-K cells was assessed. Using a one-way ANOVA, a significant 
effect was observed between treatment groups and controls (p < 0.05) (Figures 3A and 
3B). 
 
  
 
Figure 3. Wound healing assay served as an analysis of the effects of MnO NP on cell migration 
in MODE-K intestinal epithelial cells. MODE-K cells were incubated with treatment for 24 hours. 
Measurements were taken at 0 hours and 24 hours post-treatment (Figure 3A). Values were 
plotted as the difference between the timepoints (Figure 3B). Results are a representation of 
two independent experiments containing six replicates per treatment. Different letter denotes 
difference in significant (p < 0.05) change.  
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Figure 3 (continued) . Wound healing assay served as an analysis of the effects of MnO NP on 
cell migration in MODE-K intestinal epithelial cells. MODE-K cells were incubated with treatment 
for 24 hours. Measurements were taken at 0 hours and 24 hours post-treatment (Figure 3A). 
Values were plotted as the difference between the timepoints (Figure 3B). Results are a 
representation of two independent experiments containing six replicates per treatment. Different 
letter denotes difference in significant (p < 0.05) change.  
 
 Post-hoc analysis (Tukey) indicated a significantly (p < 0.05) slower wound 
healing response when the control group was compared to the 10 µg/mL MnO NP alone 
and the 10 µg/mL MnO NP + 1 µg/mL LF82 treatment groups. In addition, analysis 
indicated a significant difference in wound healing process when the 1 µg/mL LF82 
treatment group was compared to the 10 µg/mL MnO NP alone and the 10 µg/mL MnO 
NP + 1 µg/mL LF82 treatment groups. Furthermore, analysis revealed a significant (p < 
0.05) decrease in wound healing when the 10 µg/mL MnO NP + 1 µg/mL LF82 
treatment group was compared to the 10 µg/mL MnO NP alone treatment group. An 
even more severe and significant (p < 0.05) decrease in distance traveled across gap 
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was seen when MODE-K intestinal epithelial cells were treated with MnO NP + LF82 
compared to MnO NP alone suggesting a synergistic negative effect in cell migration 
(i.e., wound healing process). 
Mitochondrial Respiration 
 Mitochondrial function plays a critical role in maintaining intestinal stemness 
and homeostasis (35). As mitochondrial dysfunction is associated with a loss of 
proliferative capacity by intestinal epithelial cells, the effects on crucial factors of 
mitochondrial respiration were measured using a mitostress test. Utilizing the Seahorse 
XFe24 Analyzer, changes in basal respiration, maximal respiration, proton leak, ATP 
production, and spare respiration capacity were measured (Figure 4).  
 
Figure 4. Mitochondrial respiration provides a robust test for analyzing the key parameters of 
mitochondrial function. Functional mitochondrial measurements are key to understanding 
cellular activation, proliferation, differentiation, and dysfunction. Any group containing MnO NP 
had higher oxygen consumption rates and impairment of mitochondrial dysfunction after 24 
hours. Data signifies that dysfunction of intestinal epithelial cell mitochondria is a MnO NP 
induced effect. 
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 Basal respiration is a measurement that shows the energetic demand of the cell 
under baseline conditions. Analysis showed significantly (p < 0.05) elevated levels of 
basal respiration in both treatments groups containing MnO NP when compared to 
medium and bacterial lysate alone, with the highest increase coming in the MnO NP 
(Figure 5).  
 
  
Figure 5. Basal respiration is a measurement that shows the energetic demand of the cell under 
baseline conditions. Basal respiration of MODE-K cells were measured after 24 hours of 
treatment incubation. Data shown is a representation of five independent wells. Significant (p < 
0.05) difference is denoted by difference in letter. 
 
  
 Another parameter measured is maximal respiration, which is a measurement of 
the maximum rate of respiration that cells can achieve when operating at maximum 
capacity. Significantly (p < 0.05) lower levels of maximal respiration were seen in cells 
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treated with the MnO NP alone and even more severe effects were observed in the 
MnO NP + LF82 treatment group (Figure 6).  
 
 
Figure 6. Maximal respiration is a measurement of the maximum rate of respiration that cells 
can achieve when operating at maximum capacity. Maximal respiration of MODE-K cells were 
measured after 24 hours of treatment incubation. Data shown is a representation of five 
independent wells. Significant (p < 0.05) difference is denoted by difference in letter. 
 
 However, in the presence of MnO NP + bacterial lysate, cells experienced a 
greater decrease in maximal respiration, although not statistically significant, indicating 
that the presence of microbial components further impacted mitochondrial respiration. 
Another parameter measured in the mitostress test is mitochondrial proton leak. 
Mitochondrial proton leak can have a major impact on mitochondrial oxidative 
phosphorylation coupling efficiency and production of reactive oxygen species. MnO NP 
caused a significant effect (p < 0.05) in mitochondrial metabolic activity as evidenced by 
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the increase in proton leak in both groups containing MnO NP suggesting that this is a 
MnO NP driven effect (Figure 7).  
 
  
Figure 7. Mitochondrial proton leak has a major impact on mitochondrial coupling efficiency and 
production of reactive oxygen species. Proton leak of MODE-K cells were measured after 24 
hours of treatment incubation. Data shown is a representation of five independent wells. 
Significant (p < 0.05) difference is denoted by difference in letter. 
 
 ATP production was another parameter that is measured during the mitostress 
test. MnO NP induced higher oxygen consumption rates as evidenced by the significant 
(p < 0.05) increase in ATP production when compared to control and bacterial lysate 
alone, with even more significant seen in the MnO NP alone treatment group when 
compared to MnO NP + bacterial lysate (Figure 8).  
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Figure 8. ATP production of MODE-K cells was measured after 24 hours of treatment 
incubation. Data shown is a representation of five independent wells. Significant (p < 0.05) 
difference is denoted by difference in letter. 
 
 Any group containing MnO NP experienced an increase in ATP production 
suggesting this to be a MnO NP driven effect. The final parameter measured in the 
mitostress test was spare capacity, which measures the capability of the cell to respond 
to an energetic demand, which can be an indicator of the cell’s fitness or flexibility. 
When compared to controls, any group treated with MnO NP had a significant (p < 0.05) 
decrease in the spare respiratory capacity suggesting that a decrease in respiratory 
spare capacity is a MnO nanoparticle driven effect independent of the presence of the 
bacterial lysate (Figure 9).  
56 
 
 
  
Figure 9. Spare capacity measures the capability of the cell to respond to an energetic demand, 
which can be an indicator of the cell’s fitness or flexibility. Spare capacity of MODE-K cells were 
measured at 24 hours post-treatment initiation. Data shown is a representation of five 
independent wells. Significant (p < 0.05) difference is denoted by difference in letter. 
 
 This data shows that dysfunction of mitochondrial activity and mitochondrial 
respiration is an effect driven by the presence of MnO NP. In addition, data suggested 
that when Mode-K intestinal epithelial cells were treated with MnO NP + bacterial lysate, 
the effects were more severe than when cells were treated with MnO NP alone in some 
of the parameters analyzed. This data suggests that in the presence of microbial 
components, mitochondrial activity suffered the most severe insult of all treatment 
groups suggesting the presence of the bacterial lysate greatly contributes to the already 
deleterious effects presented by MnO NP when assessing some of the parameters 
mitostress test. Collectively, these results show that impairment of mitochondrial 
function is an effect driven by the MnO NP but in the presence of microbial components, 
there is a greater capability to impair some aspects of the mitochondrial respiration in 
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intestinal gut epithelial cells as evidenced by the difference seen in some of the 
parameters measured in the mitostress test. 
MTS Assay 
 Mitochondrial dysfunction is associated with a loss of proliferative capacity in 
intestinal epithelial cells (35). As mitochondrial function is associated with health and 
maintenance of gut epithelial barrier, MTS assay provided crucial insight about cell 
viability and health. After 48 hours of incubation, a significant decrease was seen in the 
MnO + bacterial lysate treatment group (p < 0.05) (Figure 10).  
 
  
Figure 10. Cell viability was measured using MTS assay. As MTS assay takes into account 
three parameters (cytotoxic effect, cytostatic effect, and antiproliferative effect), any decrease in 
viability may be a result from either one or a combination of these three parameters. After 48 
hours of treatment incubation, viability of MODE-K cells was measured. Data shown is a 
representation of two independent experiments containing 6 replicates per treatment with 
significant (p < 0.05) difference denoted by difference in letter. 
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Discussion 
 The intestinal epithelial barrier, which consists of several elements including 
intestinal epithelial cells, tight junctions, and adherens junctions, prevents 
microorganisms such as viruses, as well as undesirable solutes, toxins, and luminal 
antigens from entering the body (36, 37). It is suggested that disruption of the intestinal 
barrier function and repeated intestinal epithelial damage are key features of IBD, as 
well as other intestinal disorders (34, 8). As IBD has multifactorial etiology and is an 
interaction between factors such as genetics, microbiota, immune response and 
environment, there needs to be more studies to investigate the contribution of these 
nanoparticles and environmental factors. The occupational environment in manganese 
ore processing, metallurgy, metalworking, and welding is a potential source of increased 
exposure to MnO NP via inhalational and ingestion (47). MnO NP have been shown to 
cause impairment of dopaminergic neurons and induce inflammation in the brain (48). 
Addtionally, MnO NP have been shown to cause an increase in oxidative stress and 
apoptosis in alveolar epithelial cells (47). However, not much studies have looked at the 
effects of MnO NP toxicity on intestinal epithelial cells.  This study gives new insights 
regarding the toxicity of MnO NP for intestinal epithelial cells especially in combination 
with phlogistic components from the GI lumen as most studies evaluate MnO NP alone 
which underestimates their in vivo toxicity. By themselves, MnO NP negatively affected 
the MODE-K epithelial cells but in the presence of bacterial lysate, synergistic effects 
are seen in several biological functions including inflammatory cytokine production and 
wound healing. Therefore, we can conclude that a combination of MnO NP and a 
bacterial lysate induced cytotoxic effects more severely than MnO NP alone.  
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Because manganese ions were detected in culture supernatants (data not 
shown), it is possible that excessive Mn++ ions in the culture medium could impact other 
mitochondrial functions (38). Mn has an essential role in the survival and death 
mechanisms in cells of all organisms because it regulates Mn-containing enzymes such 
as manganese superoxide dismutase (SOD2) and regulates expression and activity of 
caspases. Accumulation of Mn to excessive levels has been shown to cause cellular 
dysfunction and cell death (38). The effects seen in mitochondrial dysfunction are 
associated with deleterious effects seen in cellular migration results shown in the wound 
healing assay suggesting possible correlation between mitochondrial dysfunction and 
the wound healing response. Data suggest the presence of MnO NP led to an 
accumulation and excess level of Mn++ in IECs that disrupted the balance of the redox 
interaction and caused mitochondrial dysfunction. This led to deleterious effects in 
wound healing response that we saw in this study. Control of intestinal epithelial 
stemness is crucial for tissue homeostasis and the mitochondrial function plays a critical 
role in maintaining intestinal stemness (42). Dysfunction of the mitochondria was 
accompanied by impairment in ATP production which resulted in reduced proliferation of 
the intestinal epithelium and loss of stemness (42). As our study shows that MnO NP 
(exacerbated with LF82) can cause impairment of mitochondrial respiration of MODE-K 
cells, we predict that the presence of MnO NP in the gut in vivo will affect the 
mitochondrial energy capacity of IECs and consequently the stemness of the intestinal 
epithelium and lead to subsequent impairment in barrier formation that will result in a 
leaky gut. 
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Mitochondria play an important role during the interaction of gut microbiota with 
host cells and mitochondrial activity may be an important factor that modulates 
microbiota diversity and quality (43).  A study performed using colonic biopsy samples 
showed that induced mitochondrial dysfunction affected epithelial barrier function, which 
allowed transepithelial flux of bacteria across the intestinal epithelial barrier (44). An 
extraordinary amount of energy is required and being turnover during the inflammatory 
and immune responses (45). For example, the first contact of the gut microbiota with the 
intestinal epithelium stimulates toll-like receptors in IECs which results in the recruitment 
of immune cells that subsequently produce IgA to limit the over-colonization of gut 
microbiota (46). Based on the described in vitro studies, it is predicted that MnO NP will 
dysregulate the in vivo mitochondrial function leading to a loss in epithelial barrier 
integrity and the infiltration of gut microbes subsequently inducing an elevated 
proinflammatory response (46). Based on our study, we predict that MnO NP, which have 
been shown to induce mitochondrial dysfunction and cause synergistic inflammatory 
response, this process will be dysregulated leading to an infiltration of gut microbes 
across the intestinal epithelium and subsequently an elevated proinflammatory 
response.  
The GI tract has been shown to be the primary route of ingestion and excretion 
for metal nanoparticles. The results of these studies show that the addition of bacterial 
components to intestinal epithelial cells treated with MnO NP might be predictive of the 
cellular response seen in vivo as this represents a realistic exposure. Currently, the 
toxicity of nanoparticles is evaluated with various approaches that include both in vitro 
and in vivo methods of assessment but rarely do they take into consideration the 
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presence of the microbial community that exist in the body. Additionally, nanoparticle 
studies that take into consideration the interaction between nanoparticles and 
environmental components (e.g., microbiota) are extremely limited. The results of the 
present study demonstrate that there is a necessity to integrate the contribution of other 
stimuli present in the gut, such as microbial components and/or inflammatory cytokines, 
on IEC health and ultimately intestinal barrier integrity as this represents a more holistic 
approach that more closely mimics the gut environment. 
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COMBINATION WITH INFLAMMATORY MEDIATORS ON INTESTINAL    
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Abstract 
Titanium dioxide nanoparticles (TiO2 NP) are commonly found in many food 
products such as donuts, chewing gums, milk-based products, chocolate, and products 
with white icing or powdered sugar toppings. Despite being found in many consumed 
food products, little is known about the fate, toxicity, and potential deleterious effects of 
TiO2 NP to affect cellular functions of intestinal epithelial cells critical to the maintenance 
of the epithelial barrier along the gastrointestinal (GI) tract. Furthermore, TiO2 NP has 
been shown to be aggregated in the ileum, which is the region of the GI where the onset 
of inflammatory bowel disease (IBD) has been shown to develop. GI research has 
shown that maintenance of the epithelial barrier plays a critical role in mucosal 
homeostasis and immunity as evidenced in a number of GI disorders including IBD, 
which occurs in about 1 in 300 persons worldwide. Despite this data, there is no study 
assessing the direct effects of TiO2 NP in combination with host inflammatory mediators 
on intestinal epithelial cells. Using an in vitro model of GI homeostasis and epithelial 
wound healing, we examined the effects of TiO2 NP alone or in combination with 
inflammatory mediators (TNFα/IFNγ). We hypothesized that treatment with TiO2 NP in 
combination with a bacterial lysate will induce adverse and deleterious effects on 
                                                          
1 Graduate student and Professor, respectively, Department of Veterinary Microbiology and Preventive 
Medicine, Iowa State University. 
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intestinal epithelial cells. Specifically, MODE-K cells, a murine intestinal epithelial cell 
line, were exposed to TiO2 NP alone or in combination with TNFα/IFNγ for 24 hours. 
Compared to TiO2 NP alone, these studies demonstrated that the addition of TiO2 NP 
plus TNFα/IFNγ resulted in 1) exacerbated deleterious effects of MODE-K cells 2) 
potentiated mitochondrial superoxide generation 3) negatively affected cell migration as 
evidenced by wound healing assay, and 4) enhanced secretion of inflammatory 
cytokines such as IL-6. While the TNFα/IFNγ had no deleterious effects on the MODE-K 
cells data suggests that in the presence of TNFα/IFNγ, TiO2 NP had potentiating effects 
on intestinal epithelial cells that adversely affect intestinal epithelial barrier which can 
lead to a negative impact on mucosal homeostasis. 
Introduction 
 Titanium dioxide nanoparticles (TiO2 NP) are commonly found in many food 
products such as donuts, chewing gums, milk-based products, chocolate, and products 
with white icing or powdered sugar toppings (1-3). Despite being found in many 
consumed food products, little is known about the fate, toxicity, and potential deleterious 
effects of TiO2 NP to affect cellular functions of epithelial cells critical to the 
maintenance of the epithelial barrier along the gastrointestinal tract (GIT). Because of 
novel properties offered by their size, nanoparticles (NP) are being introduced into a 
rising number of food products (www.nanotechproject.org) as an FDA approved additive 
used as a food colorant (4). However, data that have shown that TiO2 NP can be toxic to 
epithelial cells and to induce deleterious biological effects (5). For example, TiO2 NP 
pretreated with digestive fluids, which included saliva, gastric, duodenal, and bile fluid, 
inhibited cell growth in undifferentiated Caco-2 cells (5). In addition to inhibiting growth, 
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these TiO2 NP can be taken up by IECs resulting in translocation across the intestinal 
epithelium (6, 7). Compared to uptake by M cell overlying the Peyer’s patches, 
translocation occurs diffusely along the entire length of the GIT and, given the amount 
of TiO2 NP that may be consumed, the total uptake of ingested TiO2 NPs may be 
important given the large surface area of the GI epithelium (7). Collectively, these 
previous studies point out that TiO2 NP possess the ability to have adverse cytotoxic 
effects on intestinal epithelial cells (IECs). Despite this data, there are virtually no 
studies assessing the direct effects of TiO2 NP on IECs and the mechanisms by which 
these effects occur. It has been suggested that ROS production is the main cytotoxic 
mechanism affecting various cell types (8-10). However, there have been no studies 
found investigating these mechanisms of action of TiO2 NP in IECs.  
In vitro studies have identified several biochemical changes indicative of 
oxidative stress and inflammation induced by exposure of keratinocytes to TiO2 NP (11, 
12).  In keratinocytes, TiO2 NP have been shown to affect the glucuronidation pathway, 
which is a major pathway for metabolizing xenobiotics, by decreasing the two major 
cofactors, UDP-glucuronate and glucuronate (12). Several studies established the 
consequential effects of TiO2 NP exposure on cells and tissues, such as ROS induction 
and inflammatory cytokine production, often associated with carcinogenesis (8-12). TiO2 
NP have also been shown to be taken up from the lumen of the GIT (3, 13). An in vivo 
study revealed TiO2 NP uptake from the GIT via the Peyer’s patches. The sampling 
proficiency of M cells leads to a relative high concentration of TiO2 NP in the lymphoid 
tissues of mice (3, 13, 14). TiO2 NP translocating across the epithelial barrier would induce 
a loss of epithelial integrity and linger in gut cells or interstitial spaces where they could 
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become toxic and potentially trigger impairment of GIT function (7). Consequences of the 
chronic damage associated with the presence of TiO2 NP may include, but is not limited 
to, changes in expression of genes necessary for cell survival, inflammation, apoptosis 
and cell cycle, and with down-regulation of genes involved in energy metabolism (7). 
Understanding the effect of TiO2 NP on epithelial cells, intestinal barrier function, and 
absorption of these nanoparticles is essential and vital for assessing the safety of orally 
administrated or consumed TiO2 NP (5).  
 The increasing interest in the use of nanoparticles, including TiO2 NP, in the food 
industry has led to immense enthusiasm about possible advantages, such as improving 
the appearance of foods, but also worry over their potential to cause cytotoxic effects 
(15). With the growing concerns that have arisen about unintentional biological effects of 
nanoparticles, there needs to be more in-depth evaluation of the effects that TiO2 
nanoparticles may have on biological systems (16). For example, metal-based 
nanoparticles can be present at low levels but then accumulate to concentrations that 
disrupt intracellular trafficking leading to deleterious effects on gene expression in 
genes, such as gluthathione peroxidases and superoxide dismutase 3 (SOD3), which 
are responsible for antioxidant activity in cells (17). More complete understanding of the 
basis of metal-based nanoparticle toxicity is essential for the complete risk-assessment 
of NP exposure on occupational, environmental, and human/animal health. 
Understanding underlying process and mechanisms from administration to excretion 
must be completely assessed and understood because nanoparticles, such as TiO2 NP, 
are currently being used in the food industry. As a result, the GIT will be the primary 
route of entry and excretion for some of these nanoparticles TiO2 NP (18, 19). However, 
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there are currently no studies performed that assessing the effects and interactions 
between TiO2 NP and inflammatory mediators on IECs.  
Assessing the effects of nanoparticles on IECs in the presence of host 
inflammatory cytokines and/or phlogistic components from the GI lumen presents a 
more holistic and realistic cellular response when assessing effects of metal NPs on gut 
epithelial cells knowing that immune responses influence physiological, metabolic, 
nutritional, and microbiological functions that have been linked with GI conditions such 
as inflammatory bowel disease (20). Based on this information, we hypothesize that the of 
TiO2 NP in conjunction with host inflammatory cytokines will have deleterious effects on 
the health of intestinal epithelial cells. We showed that some of the cellular functions 
necessary for the maintenance of the intestinal epithelial barrier were inhibited after 
treatment with TiO2 NP and inflammatory mediators. 
Materials and Methods 
Nanoparticles 
 Titanium dioxide nanoparticles (TiO2 NP) used in all experimental procedures 
were purchased from US Research Nanomaterials, Inc. (Houston, TX, USA). Particles 
were suspended in low glucose (1 g/L) DMEM at a stock concentration of 2 mg/mL prior 
to addition to the cells. TiO2 NP used in this study were less than 25nm in diameter.  
Cytokines 
 Murine tumor necrosis factor-alpha (TNFα) and interferon-gamma (IFNγ) were 
used in all experimental procedures and were purchased from Peprotech (Rocky Hill, 
NJ, USA).  TNFα and IFNγ cytokines were suspended in complete low glucose DMEM 
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culture medium at 10 µg/mL and 100 µg/mL, respectively, and then stored frozen at -
80° C until used. 
Cell Culture and Treatment 
 MODE-K epithelial cells derived from the small intestine of a C3H mouse was 
used in all experimental procedures described below (kind gift from Dr. C. Elson). In this 
study, MODE-K cells were grown in high glucose (4.5 g/L) DMEM medium containing 
10% FBS, 2 mM L-glutamine, 50 units of penicillin, and 50 mg/mL streptomycin 
(complete medium). In general, cells were seeded in a tissue culture plate in 
accordance to the experimental requirements and were cultured overnight in a 
humidified atmosphere of 5% CO2 at 37 °C. The length of each experiment and cell 
density used for each experiment has been provided in the methods section for each 
experimental procedure. The four treatment groups for experimental procedures were: 
medium alone, 5 ng/mL TNFα/IFNγ (2.5 ng/mL of each cytokine), 50 µg/mL TiO2 NP, 
and 50 µg/mL TiO2 NP + 5 ng/mL TNFα/IFNγ. All experiments were conducted in low 
glucose (1.0 g/L) DMEM medium. To optimize the amount of cytokine used in these 
studies, dose titrations were performed with TNFα/IFNγ to find doses that had minimal 
effects on the MODE-K cells (e.g., viability) and these minimal doses were chosen in 
order to facilitate the ability to assess the interactions between the TiO2 NP and these 
host inflammatory mediators.  
Mitochondrial superoxide generation 
 Mitochondrial superoxide generation was measured using MitoSOXTM Red 
Mitochondrial Superoxide Indicator following the manufacturer’s instructions (Thermo 
Scientific). The four treatment groups for experimental procedures were: medium alone, 
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5 ng/mL TNFα/IFNγ (2.5 ng/mL of each cytokine) only group, 50 µg/mL TiO2 NP only 
group, and 50 µg/mL TiO2 NP + 5 ng/mL TNFα/IFNγ group. MODE-K cells were plated 
in 96-well plates with 8,000 cells/well one day prior to treatment and allowed to attach 
overnight. The next day cells were washed twice with low glucose DMEM medium 
before being plated with respective treatments in low glucose DMEM medium for a 
period of 24 hours. Following treatment, MitoSox reagent was added to each plate well 
at a 1:1000 concentration. Relative fluorescence intensity was then acquired 24 hours 
post-treatment using a microplate reader.   
Cytokine Release analysis 
 Prior to assessing cell viability, supernatants were collected from MODE-K cell 
cultures at 24 and 48 hours after addition of the TiO2 NP or other stimulants and 
analyzed for the presence of cytokines. A multiplex assay was used to detect the 
presence of IL-6, TNFα, and IFNγ. The cytokines in each sample of the supernatant 
were measured using multiplex bead analysis for immunoassays. Standard curves were 
generated using Bio-Plex Manager Software Version 6.0 (Bio-Rad Laboratories, Inc., 
Carlsbad, CA, USA) and the amount of cytokine in each sample was determined. 
Wound Healing Assay 
 For one-dimensional cellular migration assays, 300,000 MODE-K cells were 
resuspended in DMEM (low glucose, 1.0 g/L) inoculated into 12 well plates and 
incubated overnight. Before the experiment, cells were confluent and quiescent in low 
glucose DMEM (the overnight medium). At the beginning of the experiment, a (+) 
shaped gap was created in each well using a P-200 pipet tip creating a cell free gap 
that, in time, would be covered by replicating/migrating MODE-K cells. Cells were then 
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incubated. Images were taken at 0 and 24 hours post-wounding. The four treatment 
groups for experimental procedures were the same as described above. After 24 hours, 
experiments were terminated. Images were taken using a 5x objective on an inverted 
microscope Leica DMi1 (Leica Microsystems, IL, US) using the software Leica 
Application Suite 4.5.0 (Leica Microsystems, IL, US) from 10 representative wounded 
areas per condition. Images and gap spacing were then measured and analyzed with 
an automation and image analysis software Metamorph 5.0.7 (Molecular Devices LLC, 
CA, US). Gap closure was quantified by determining the mean distance of closure of the 
gap. This was done by measuring the area of the cell-free space dividing the length of 
the gap at 24-hours, and then subtracting this value from starting value that was 
measured at 0-hour. This method was previously described and adopted to fit our 
experimental procedure (21). 
Mitochondrial Respiration 
 Mitochondrial oxygen consumption rates were measured using a Seahorse 
XF24e Extracellular Flux analyzer (Seahorse Bioscience, North Billerica, MA). The 
Seahorse XF24e Extracellular Flux analyzer is a high-throughput instrument that yields 
real-time measurements of cellular respiration rates. In our studies, we were interested 
in assessing the effects of our treatments on mitochondrial respiration and the effects of 
our treatments on oxygen consumption rates (OCR). Cells were seeded at a density of 
300,000/ml into a T-25 culture flask and incubated overnight in 5% CO2 at 37.8 ºC. The 
next day cells were treated with respective treatments for 24 hours. Stimulated cells 
were recovered from the plates by scraping and added to the Seahorse plates using 
CellTac at 60,000 cells per well and incubated for 1 hour to allow the cells to adhere. At 
73 
 
 
this time, the mito-stressor reagents Oligomycin (1 µM), FCCP (2 µM) and 
Rotenone/Antimycin A (0.5 µM) were loaded into the corresponding injection ports of 
the Seahorse FluxPak cartridge and placed in the Seahorse analyzer to be equilibrated. 
After equilibration, the plate containing treated cells was then placed in the Seahorse 
analyzer covered with the Flux Pak cartridge. The analyzer was then programmed to 
measure the basal OCR readouts at five specified time intervals before progressing to 
inject the mito-stressors. Measuring mitochondrial respiration with the Seahorse 
analyzer allowed us to determine the effect of each treatment on the three critical 
stages of respiration. The first stage involves the addition of an ATP synthase inhibitor, 
oligomycin, which suddenly decreases the OCR. The next stage is the addition of 
FCCP, which acts as an uncoupler that increases mitochondrial oxygen consumption by 
disinhibiting the flow of protons across the mitochondrial inner membrane due to 
uncoupling of the electron transport chain. The final stage is the addition of 
rotenone/antimycin A, which is a respiratory chain inhibitor that completely shuts down 
mitochondrial activity. 
Statistical Analysis 
 All statistical data analyses were performed using Prism 4.0 (GraphPad 
Software, San Diego, CA). Data were analyzed using one-way ANOVA with the Tukey 
post-test for comparing all treatment groups with that of the control. Multiple 
comparisons test was also performed to analyze differences between treatment groups. 
Differences with p < 0.05 were considered significant. All data is representative of two 
independent experiments. Data is representative of two independent experiments 
containing six wells per treatment. 
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Results 
Mitochondrial Superoxide Generation 
The presence of reactive oxygen species (ROS) may negatively impact the 
barrier function of the GI epithelium. An increase of ROS in the inflamed mucosa of 
inflammatory bowel disease (IBD) patients has been reported and may contribute to 
loss of intestinal barrier function (22). Furthermore, during inflammation, oxidative stress 
can lead to the induction of cell injury and apoptosis of intestinal epithelial cells (23). As 
an intestinal epithelial cell model, murine MODE-K cells were used to evaluate the effect 
of TiO2 NP on critical cell functions associated with formation and maintenance of 
epithelial homeostasis. After 24 hours of incubation with each treatment, mitochondrial 
superoxide generation was measured. Data was normalized to percent control.  
 
Figure 1. Mitochondrial superoxide generation was measured from MODE-K intestinal 
epithelial cells 24 hours post-treatment. Data was normalized to percent control. Data 
presented is a representative of two independent experiments containing six replicates per 
treatment. Different letter denotes difference in significance (p < 0.05). 
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Significant (p < 0.05) difference was seen when any treatment group containing 
TNFα/IFNγ, whether TNFα/IFNγ alone treatment group or TiO2 NP + TNFα/IFNγ group, 
was compared to the TiO2 NP alone treatment group (Figure 1). There was at least a 
12% increase in mitochondrial superoxide generation in both treatment groups 
containing TNFα/IFNγ indicating that generation of mitochondrial superoxide generation 
was cytokine driven and not related to the presence of the TiO2 NP. Interactions 
between TiO2 NP and a bacterial lysate generated from E. coli LF82 were also 
evaluated but bacterial lysate did not exacerbate any deleterious effects when added in 
combination with the TiO2 NP (data not shown).  
Wound Healing Assay 
Wound healing is a crucial function of the intestinal epithelium as it can be injured 
by toxic substances from the lumen, normal digestion, inflammation, interactions with 
microbes, oxidative stress, and/or pharmaceuticals (22, 24). Upon injury and loss of 
epithelial cells, the intestinal epithelium undergoes a wound healing process which is 
dependent on the balance of three cellular events; proliferation, differentiation, and 
restitution of epithelial cells adjacent to the wounded area (25). Therefore, to address the 
impact to TiO2 NP on cellular proliferation, we used a scratch wound assay (21). After 
“wounding” the MODE-K cell monolayer, measurements of the gap were taken at 0 
hours post-wounding and then again at 24-hours post-treatment. 
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Figure 2. Wound healing assay served as an analysis of the effects on cell migration in MODE-
K intestinal epithelial cells. Measurements were taken at 0 hours and 24 hours post-treatment. 
Values were plotted as the difference between the timepoints. Results are representative of two 
independent experiments containing six replicates per treatment. Different letter denotes 
difference in significant (p < 0.05) change. 
 
 
A significant effect was observed between treatment groups and controls (p < 
0.05). Furthermore, there was significantly (p < 0.05) slower wound MODE-K cell 
replication in the TiO2 NP + TNFα/IFNγ treatment group when compared to the TiO2 NP 
only treatment group (Figure 2). There was no significant difference seen when the 
TNF/IFN treatment group and the TiO2 NP only group were compared to each other. As 
immune stimulatory molecules are continually present in GI tissue, the epithelial barrier 
will face persistent interactions from both the microbiota and innate and adaptive  
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immune response. As cellular migration is an important component in the turnover 
process of epithelial cells in order to maintain integrity of the epithelial barrier, the 
results in the wound healing assay shows that TiO2 NP alone can hinder epithelial 
replication and/or migration. Furthermore, in the presence of host inflammatory 
cytokines, the deleterious effects on MODE-K cells induced by TiO2 NP are 
exacerbated. 
Cytokine Release 
Damage and impairment of the intestinal surface barrier may result in an 
increased penetration and absorption of toxic and phlogistic components across the 
epithelium leading to inflammation, uncontrolled innate immune response, and 
disequilibrium of mucosal homeostasis (26). This inflammatory response can lead to the 
induction of cellular injury and apoptosis of intestinal epithelial cells (23, 26). Therefore, 
cytokine analysis was performed to address the ability of TiO2 NP to stimulate MODE-K 
cells. After 24 hours of incubation, supernatants were harvested and cytokine levels 
were measured. A significant (p < 0.05) induction of IL-6 was observed between 
treatment groups (p < 0.05) (Figure 3A).  
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Figure 3. Supernatants from each well were taken at 24 hours post-treatment and individually 
measured for IL-6 cytokine release from MODE-K intestinal epithelial cells (Figure 3A). Then, 
supernatants from each well were taken at 48 hours post-treatment and individually measured 
for IL-6 cytokine (Figure 3B). Data shown is representative of two independent experiments 
containing six replicates per treatment. Different letter denotes difference in significant (p < 
0.05) change. 
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 Post-hoc analysis indicated significantly (p < 0.05) higher IL-6 production when 
MODE-K cells were stimulated with TiO2 NP in the presence of TNFα/IFNγ compared to 
the control group. In addition, analysis indicated a significant (p < 0.05) increase in IL-6 
secretion from MODE-K cells treated with TNFα/IFNγ alone when compared to cells 
treated with TiO2 NP alone. Furthermore, analysis revealed a significant (p < 0.05) 
increase in IL-6 secretion at both 24 hours (Figure 3A) and 48 hours (Figure 3B) post-
stimulation when the TiO2 NP + TNFα/IFNγ treatment group was compared to cells 
treated with TiO2 NP alone. The results of cytokine release revealed a synergistic effect 
on IL-6 secretion release when TiO2 NP was combined with TNFα/IFNγ. 
Mitochondrial Respiration 
Mitochondrial function plays a critical role in maintaining intestinal stemness 
and homeostasis (27). As mitochondrial dysfunction is associated with a loss of 
proliferative capacity in intestinal epithelial cells, the effects on crucial stages of 
mitochondrial respiration was measured as described in Materials and Methods. 
Utilizing the Seahorse XFe24 Analyzer, the parameters measured to assess 
mitochondrial stress included basal respiration, maximal respiration, proton leak, ATP 
production, and spare respiratory capacity (Figure 4).  
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Figure 4. Mitochondrial respiration provides a robust test for analyzing the key parameters of 
mitochondrial function. Functional mitochondrial measurements are key to understanding 
cellular activation, proliferation, differentiation, and dysfunction. Mitochondrial function of 
MODE-K cells were measured after 24 hours of treatment incubation. The parameters 
measured were basal respiration, maximal respiration, proton leak, ATP production, and spare 
capacity. 
 
Basal respiration is a measurement that shows the energetic demand of the cell 
under baseline conditions. Analysis showed significantly (p < 0.05) elevated levels of 
basal respiration in both groups of MODE-K cells treated with TiO2 NP when compared 
to control and TNFα/IFNγ groups (Figure 5).  
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Figure 5. Basal respiration is a measurement that shows the energetic demand of the cell under 
baseline conditions. Basal respiration of MODE-K cells were measured after 24 hours of 
treatment incubation. Data shown is a representative of six independent experimental wells. 
Significant (p < 0.05) difference is denoted by difference in letter. 
 
Maximal respiration was another parameter measured which represents the 
maximum rate of respiration cells can achieve when operating at maximum capacity. 
Significantly (p < 0.05) higher levels of maximal respiration were observed in all 
treatment groups receiving TiO2 NP when compared to control and TNFα/IFNγ 
treatment groups (Figure 6).  
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Figure 6. Basal respiration is a measurement that shows the energetic demand of the cell under 
baseline conditions. Basal respiration of MODE-K cells were measured after 24 hours of 
treatment incubation. Data shown is a representative of six independent experimental wells. 
Significant (p < 0.05) difference is denoted by difference in letter. 
 
Another functional parameter measured was mitochondrial proton leak which can 
have a major impact on the coupling efficiency of Complexes I through IV in the 
mitochondrial membrane. While significant differences (p < 0.05) were induced in 
MODE-K cells treated with TiO2 NPs in comparison to the other treatment groups 
(Figure 7).  
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Figure 7. Mitochondrial proton leak has a major impact on mitochondrial oxidative 
phosphorylation coupling efficiency and production of reactive oxygen species. Proton leak of 
MODE-K cells were measured after 24 hours of treatment incubation. Data shown is a 
representative of five independent experimental wells. Significant (p < 0.05) difference is 
denoted by difference in letter. 
 
ATP production, which measures ATP produced by the mitochondria that 
contributes to meeting the energetic needs of the cell, was another parameter that was 
measured following the addition of the TiO2 NPs. Incubating MODE-K cells in the 
presence of TiO2 NP or TiO2 NP + TNFα/IFNγ treatment group caused a significant (P < 
0.05) increase in ATP production when compared to control treatment group, with the 
highest increase seen in the TiO2 NP only group (Figure 8).  
84 
 
 
  
Figure 8. ATP production of MODE-K cells was measured after 24 hours of treatment 
incubation. Data shown is a representative of five independent experimental wells. Significant (p 
< 0.05) difference is denoted by difference in letter. 
 
 
The presence of TiO2 NP, alone or in combination with TNFα/IFNγ, result in at 
least a 45% increase in oxygen consumption in MODE-K cells suggesting an increase 
in metabolic activity.  
Lastly, respiratory spare capacity was measured which approximates the 
capability of the cell/mitochondria to respond to an energetic demand and is used as an 
indicator of the cell’s fitness or flexibility. When compared to control treatment group, 
any group treated with TiO2 NP had higher levels of spare capacity. This suggests that 
changes to spare capacity appears to be a TiO2 NP driven effect (Figure 9).  
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Figure 9. Spare capacity measures the capability of the cell to respond to an energetic demand, 
which can be an indicator of the cell’s fitness or flexibility. Spare capacity of MODE-K cells were 
measured at 24 hours post-treatment initiation. Data shown is representative of five 
independent experimental wells. Significant (p < 0.05) difference is denoted by difference in 
letter. 
 
In addition, data suggested that when MODE-K cells were treated with TiO2 NP + 
TNFα/IFNγ, the magnitude of the spare capacity was less robust than when cells were 
treated with TiO2 NP only suggesting that host inflammatory response plays a role in 
ameliorating mitochondrial respiration. Collectively, these results show that changes in 
mitochondrial function in MODE-K cells exposed to the TiO2 NPs is an effect driven by 
the presence of the TiO2 NPs as opposed to TNFα & IFNγ. 
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Discussion 
 The intestinal epithelial barrier, which consist of several elements including 
intestinal epithelial cells, tight junctions, and adherens junctions, prevents undesirable 
solutes such as microorganisms, viruses, toxins, and luminal antigens from entering the 
body (28, 29). It is suggested that disruption of the intestinal barrier function and 
repeated/chronic intestinal epithelial damage are key features of IBD, as well as other 
intestinal disorders (26, 29). This study gives insight into potential deleterious effects 
associated with GIT exposure to TiO2 NPs in combination with inflammatory cytokines 
on the maintenance of intestinal epithelial barrier. By themselves, TiO2 NP did not prove 
to be cytotoxic to MODE-K intestinal epithelial cells. However, when MODE-K were 
treated with TiO2 NP in combination with TNFα/IFNγ, data showed that this combination 
negatively affected biological functions such as epithelial restitution which play major 
roles in the health, formation, and maintenance of the intestinal epithelial barrier.  
This study concluded that inhibition in cellular function, as evidenced by MODE-K 
cell replication, were observed and were more severe as early as 24 hours after 
exposure to TiO2 NP + TNFα/IFNγ than cells treated with TiO2 NP alone. As 
mitochondrial reactive oxygen species may also be involved in the regulation of the gut 
epithelial barrier, induced mitochondrial dysfunction can affect epithelial barrier and the 
permeability of the GI epithelium. (30). Due to the substantial amount of energy 
necessary and used during the inflammatory and immune responses, mitochondrial 
activity has a crucial role in the interaction between gut microbiota and host epithelial 
cells (31, 32). Based on the results herein, it is hypothesized that IECs treated with TiO2 
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NP in the presence of microbial components and host inflammatory mediators will 
demonstrate adverse responses such as wound healing and cellular migration as well 
as actin and cytoskeleton rearrangement. 
With the goal to improve the appearance of foods, the usage of nanoparticles 
specifically TiO2 NPs, the GIT will be exposed to moderate to excessive levels of these 
nanoparticles. While TiO2 NPs are found in powdered-sugar donuts, the highest levels 
of TiO2 NP are found in products such as chewing gum, milk-based products, chocolate, 
tablets of dietary supplements, and products with white icing (1). Microparticles of TiO2 
have been shown to amass in macrophages within the mucosal associated lymphoid 
tissue (MALT) of the human GIT. In addition, sites of the greatest uptake of TiO2 NPs 
are similar to the tissue locations (ileum) where the initial lesions of Crohn’s disease are 
seen (33). Although levels of TiO2 NPs tested in the present study did not induce 
cytotoxic effects, in the presence of host inflammatory cytokines, such as TNFα and 
IFNγ, the presence of TiO2 NPs were shown to impair biological functions and 
processes that would be necessary for formation and maintenance of the intestinal 
epithelial barrier. it is estimated that daily human intake is within the range of 15-37.2 
mg/day for a 75-kg adult (7). Because the GIT is the primary route of intake and 
excretion of TiO2 NP, the intestinal epithelial barrier will be consistently exposed to TiO2 
NP beyond the concentration and time range used in the present in our vitro studies. 
Furthermore, the inclusion of pro-inflammatory cytokines in the experimental design 
provided a more holistic and realistic model to assess the impact of TiO2 NP exposure 
on IECs. Currently, the toxicity of nanoparticles is evaluated with various approaches 
that include both in vitro and in vivo methods but rarely do they take into consideration 
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the presence of microbial contributions and/or the host innate immune response (e.g., 
inflammatory cytokines).  
Lastly, proper studies and screening techniques will need to be carefully 
considered and tailored for each cell of interest when assessing toxicity of 
nanoparticles. For example, as microbial components and host inflammatory mediators 
are present in the gut, these co-stimulatory mediators can change how a cell responds, 
which in turn can change the physiological outcome and cellular metabolism. Therefore, 
when assessing toxicological effects of nanoparticles on the GIT, it is necessary to 
factor in the above-mentioned components in order to mimic the in vivo environment of 
IECs and assess the interactions between those factors and the NPs. A failure to 
consider these factors might downplay level the toxicity of these NPs. Furthermore, in 
vitro studies utilizing nanoparticles give a limited view of deleterious effects due to finite 
number of cells in experiments. For nanoparticles, such as TiO2 NP which are widely 
used as a food colorant, there needs to be more in depth and long-term in vivo studies 
that can account for extended exposure to TiO2 NPs in order to fully assess the 
toxicological effects on the GIT and intestinal epithelium associated with chronic 
consumption. 
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CHAPTER 5. GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
 
This section presents an overview of the results and findings of this dissertation, 
with a special emphasis on overall implications as they relate to: 1) assessment of the 
intestinal epithelial barrier when evaluating toxicological effects of nanoparticles and 2) 
the need to consider more holistic approaches when assessing toxic effects of 
nanoparticles in vivo. A discussion of the major findings for each research chapter 
included in this dissertation are covered in the respective Discussion section. 
Importance of Assessing the Intestinal Epithelial Barrier and the Importance of 
Holistic Approaches When Assessing the Toxicity of Nanoparticles 
 
Intestinal epithelial cells (IECs) play a critical role in formation and maintenance 
of the intestinal epithelial barrier which functions as a protective barrier from xenobiotics 
and foreign substance. Rather than focus on the response of inflammatory cells (e.g., 
macrophages, PMNs), it is necessary to include an assessment of the intestinal 
epithelial barrier in toxicity studies assessing cellular and/or molecular interactions with 
nanoparticles. Collectively, the results presented in the Chapters of this dissertation 
highlighted the fact that different effects were manifested on IECs by different metal 
oxide nanoparticles. This points out that there is a need to assess the impact of 
nanoparticles based on their composition and not on the size of the particle. 
Additionally, there is a need to include an assessment of the bioenergetics, metabolic 
effects and mitochondrial function of IECs as well as our studies have shown that an 
impairment in the mitochondrial respiratory capacity negatively affected IECs and 
cellular functions that play a critical role in the formation of intestinal epithelial barrier 
such as wound healing.  
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In Chapter 2, MnO NPs severely impacted mitochondrial function as evidenced 
by impairment of mitochondrial respiration. As manganese (Mn) plays an essential role 
in biological functions (i.e., antioxidant enzymes) important to the function of the 
mitochondria, the presence of MnO NP, which were shown to release Mn++, severely 
impairs mitochondrial function. Mitochondrial respiratory chain consists of four 
complexes (Complex I, II, III, and IV) with functions in the electron transport chain that 
include ATP production via oxidative phosphorylation that is crucial for basal respiration, 
maximal respiration, and spare respiratory capacity which are all key factors in the 
metabolic function of cells. Impairment of these complexes have been shown to 
negatively affect oxidative phosphorylation resulting in effects ranging from the release 
of reactive oxygen species to the induction of apoptosis. Our studies show that MnO NP 
interferes and disrupts the function of these complexes in the mitochondrial electron 
transport chain. In addition, when MnO NP are in the presence of microbial components 
(i.e., TLR ligands), these effects are exacerbated as the interaction between the two 
have been overlooked.  
Increase in GI disease has risen much more rapidly in Western societies than 
can be accounted for by genetic changes alone; however, environmental factors, such 
as metal oxide particles, are continuously being introduced into multiple aspects of 
everyday life. As IECs are exposed to antagonistic, environmental cofactors, 
mitochondrial impairment and inflammatory mediators, the toxic effects of these metal 
oxide nanoparticles have the potential to have synergistic deleterious effects that affect 
processes necessary for maintenance and formation of the intestinal epithelial barrier. 
As microbial components stimulate cells via Toll-like receptors, the additional presence 
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of MnO NP impair mitochondrial function resulting in IECs becoming biologically 
overwhelmed leading to their impairment. As mitochondrial electron transport can be 
impaired, this can potentially affect other functions of the mitochondria such as 
intracellular calcium absorption which is critical to health of cells.  
In Chapter 3, the effects of TiO2 NP on the IECs were also investigated. TiO2 NP 
are found in many foods such as powdered-sugar donuts, chewing gum, milk-based 
products, chocolate, tablets of dietary supplements, and products with white icing. 
Studies. However, studies assessing the toxicity of TiO2 NP on IECs are virtually 
nonexistent. When added to IECs in combination with microbial components, TiO2 NP 
did not show any changes. However, when paired with inflammatory mediators such as 
IFNγ and TNFα, TiO2 NP induced deleterious changes in wound healing, increased 
mitochondrial superoxide generation, and increases in mitochondrial activity (see 
Chapter 3). In contrast to MnO NPs which exacerbated deleterious effects in the 
presence of bacterial components, TiO2 NPs in the presence of bacterial components 
did not exacerbate deleterious effects. Although Ti4+ (Titanium) does not have any role 
in biological functions, when in the presence of host inflammatory mediators, TiO2 NP 
were able to change the physiological and cellular metabolic function of MODE-K cells. 
This suggests that when assessing the effects of nanoparticles, it is necessary to 
consider all factors that that a cell will encounter in an in vivo environment to fully 
assess the toxicity and deleterious effects. 
In vitro studies of nanoparticles give a limited view of deleterious effects due to 
finite number of cells in experiments and acute studies. For nanoparticles such as TiO2 
NP, which are present in many foods currently on the market, there needs to be more in 
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vivo chronic studies that can account for the extended and accumulated level of 
exposures to fully assess the toxicological effects on the GI tract and intestinal 
epithelium associated with chronic consumption. As accumulation of genetic changes in 
the population do not explain the increase in GI disease seen in Western societies, it is 
necessary to start including the contribution of environmental factors as they are 
constantly and rapidly being altered and included in everyday life, including the use of 
metal oxide particles in foods such as TiO2 NPs which have been shown accumulate in 
regions of the GIT where IBD often initiates. 
For future studies, the use of primary 3D ex vivo organoid culture models for 
screening, investigating, and assessing chronic toxicological effects of nanoparticles 
could be beneficial. Using primary 3D ex vivo organoid culture models will allow for 
evaluation of primary cells while providing the opportunity for extended surveillance and 
assessment of tight junction proteins necessary for formation of the intestinal epithelial 
barrier. These tissue culture models can be passaged continuously and give insight as 
to the changes occurring at the molecular level, including epigenetic changes, after 
every passage by assessing time dependent changes between primary 3D ex vivo 
organoid culture models from different timeframes.  
When designing an experimental approach and screening techniques assessing 
the toxicity of nanoparticles, it is necessary to consider the composition of the 
nanoparticles, choose the appropriate cell line or tissue culture model and design each 
experiment to test a hypothesis. For example, IECs in the gut will either encounter 
microbial components and host inflammatory mediators or both that can change the 
physiological outcome and cellular metabolism based on how a cell responds. 
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Therefore, when investigating the toxicological effects of consumed or ingested 
nanoparticles, such as MnO2 NP and TiO2 NP, on the GI tract and gut homeostasis, it is 
necessary to factor in those components, such as the microbial interaction and the 
interaction with host inflammatory mediators, to achieve more realistic assessments. In 
conclusion, the work presented in this dissertation highlight the importance of including 
biological components that a given tissue type may encounter in vivo when designing 
an experimental approach for assessing the toxicological effects of nanoparticles so that 
the most holistic assessment of what transpires in vivo is obtained.  
It is necessary to include primary cultures of 3D organoids in this assessment as 
they can give insight to chronic and long-term effects of the NP toxicity on IECs. As the 
GI epithelium is constantly active to prevent overcolonization of gut microbes, maintain 
a clinically anti-inflammatory environment, and constantly turning over every 3-7 days, it 
is necessary to also factor in chronic effects of the environmental impacts (e.g. NPs) on 
IECs and formation of the intestinal epithelium. As we have taken initial steps towards 
adding a level of complexity to the assessment of NP toxicity on IECs, our studies have 
shown that the addition of either microbial components or host inflammatory mediators 
increase the toxicity of NPs and that IECs do not interact with these NPs in isolation. 
The next step of assessment is to use animal models that integrate both microbial 
components and host inflammatory mediators while assessing NPs toxicity to achieve 
an even more complete representation of in vivo situation than seen in our studies. 
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APPENDIX: CYTOTOXIC EFFECTS OF MANGANESE OXIDE NANOPARTICLES IN 
COMBINATION WITH MICROBIAL COMPONENTS IN INTESTINAL ORGANOIDS 
 
Introduction 
 Intestinal epithelial cells (IECs) play a role in the maintenance the intestinal 
epithelial barrier that acts as a physical barrier between our body and exogenous 
substances. Cytotoxic environments in the GI tract can cause impairment and death of 
the epithelial cells which results in the breakdown of this barrier function. This 
breakdown of the intestinal epithelial barrier can then lead to an uncontrollable 
inflammation which increases the risk of developing diseases such as IBD and other 
inflammatory diseases. Until recently, intestinal epithelial-damaging activities of 
environmental toxicants, drugs, and treatments could be tested only in vivo in animal 
models because of the poor survival rate of primary IECs ex vivo (1).  
 The three-dimensional culture and outgrowth of intestinal crypt stem cells into 
organoids have offered new possibilities to culture and study IECs ex vivo. Organoids 
represent an important bridge between traditional 2D cultures and in vivo mouse/human 
models, as they are more physiologically relevant than monolayer culture models and 
are far more amenable to manipulation of niche components, signaling pathways and 
genome editing than in vivo models (2). The organoid system allows researchers to 
intensively study the processes that govern embryonic development, lineage 
specification and tissue homeostasis, as well as the onset and manifestation of disease. 
Furthermore, organoids can be used to for modeling host– microbe interactions (3). It 
also delivers invaluable insight into the development of stem cells and their niches, 
while providing an opportunity to monitor their differentiation into mature functional 
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lineages (4). Organoids ultimately provide an opportunity to investigate the effects of 
environmental toxicants, drugs, and treatments on the development of the intestinal 
stem cells during normal and disease conditions while incorporating a more holistic 
approach that mimics the intestinal homeostatic environment that includes the host-
microbial interaction. Since intestinal stem cells in vivo are exposed to both microbial 
components that play a role in their development and maturation, we hypothesize that 
the combination of these factors will result in the enhanced toxicity of environmental 
pollutants, such as MnO NP. Therefore, to mimic the in vivo environment where 
intestinal stem cells are exposed to both environmental pollutants and microbial 
components and create a more realistic assessment, in the present study we examine 
the adverse effects of MnO NP in conjunction with bacterial lysate on intestinal 
organoids. 
Materials and Methods 
Chemicals 
 Manganese oxide nanoparticles (MnO NP (US Research Nanomaterials, Inc., 
Houston, TX, USA)) used in all experimental procedures were provided by Dr. A. 
Kanthasamy.  
Organoid Culture and Treatment 
 Organoids used in this study was provided by Dr. Qun Wang. The four treatment 
groups for the experimental procedure were: control group, 1 µg/mL bacterial lysate 
only group, 30 µg/mL MnO NP only group, and 30 µg/mL MnO NP and 1 µg/mL 
bacterial lysate group. Dose titration was performed and minimal dose was used. 
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Preparation of Bacterial Antigen 
 An adherent invasive E. coli (AIEC) strain LF82 that has been associated with 
ileal Crohn’s disease) was cultivated in BHI broth and incubated at 37 °C in an aerobic 
environment. Bacteria were harvested after overnight growth, washed with PBS, frozen, 
lyophilized, and stored at -20 °C until used. Bacterial cells were weighed and 
resuspended in sterile PBS (2 mg/ml) prior to being subjected to two freeze-thaw 
cycles, followed by sonication at 50 amps, 75 amps, and 100 amps for 30 seconds at 
each amperage. This sonication cycle was repeated three times. The bacterial lysate 
was then sterilized by ultraviolet irradiation and sterility confirmed bacteriologically. With 
minor modificatons, this method was used as previously described (5).  
MTS Cell Viability Assay 
 Cell viability was measured using the CellTiter 96 Aqueous Non-Radioactive Cell 
Proliferation (MTS assay kit from Promega Corporation, Madison, WI). Organoids were 
plated in 24-well plates one day prior to treatment with low glucose DMEM. The next 
day cells were plated with respective treatments in low glucose DMEM media for 48 
hours. Following treatment, 20 µL of MTS solution reagent mix was added to each plate 
well and incubated at 37 °C for 30 minutes. At the end of incubation, readings were 
taken at a wavelength of 490 nm and another reference reading for each well was taken 
at 670 nm to eliminate background. This method was previously described and adopted 
to fit our experimental procedure (6). 
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Results 
MTS Cell Viability 
 Mitochondrial dysfunction is associated with a loss of proliferative capacity in 
intestinal epithelial cells (7). As mitochondrial function is associated with health and 
maintenance of gut epithelial barrier, MTS proliferation and cytotoxicity assay is crucial 
for insight about cell viability and health of cell population. The four treatment groups for 
the experimental procedure were: control group, 1 µg/mL bacterial lysate only group, 30 
µg/mL MnO NP only group, and 30 µg/mL MnO NP and 1 µg/mL bacterial lysate group. 
After 48 hours of incubation with treatment, at least a 21 % decrease in mitochondrial 
activity was seen in the treatment group 30 µg/mL MnO NP and 1 µg/mL bacterial 
lysate group when it was compared to any other group (Figure 1).  
 
Figure 1. Cell viability was measured using MTS assay.  As MTS assay takes into 
account three parameters (cytotoxic effect, cytostatic effect, and antiproliferative effect), 
any decrease in viability may be a result from either one or a combination of these three 
parameters. After 48 hours of treatment incubation, viability of MODE-K cells was 
measured. There was at least a 21% decrease in viability of organoids in MnO NP + 
LF82 group when compared to any other treatment groups. 
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 The results of MTS revealed that the presence of MnO NP with bacterial lysate 
induced cytotoxicity and decreased cell viability more than any of the other treatment 
groups. As MTS assay takes into consideration three parameters (cytotoxic effect, 
cytostatic effect, and antiproliferative effect), any decrease in viability may be a result of 
either one or a combination of these three parameters that may affect health of 
intestinal organoids. 
Discussion 
 The intestinal epithelial barrier, which consists of several elements including 
intestinal epithelial cells, tight junctions, and adherens junctions, prevents undesirable 
solutes such as microorganisms, viruses, toxins, and luminal antigens from entering the 
body (8, 9). It is suggested that disruption of the intestinal barrier function and repeated 
intestinal epithelial damage are key features of IBD, as well as other intestinal disorders 
(9, 10). As organoids is a close representation of intestinal stem cells, they can give 
insight into the development of IECs and their developmental process during disease (4). 
These organoids also can be beneficial in providing details on the development of the 
intestinal epithelial barrier after encountering environmental pollutants. Results from this 
study show that treatment with MnO NP only did not affect the viability of organoids. 
However, viability of organoids in the MnO NP and bacterial lysate treatment group 
were at least 21% less when compared to any of the other treatment groups. This data 
suggests that in a more holistic environment that contains other components that are 
present in vivo, environmental pollutants, such as MnO NP, have an even more 
deleterious effect.  
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 As environmental pollutants may not have effects by themselves, the presence of 
microbial components can induce other factors such as an inflammatory response, that 
in combination with effects of environmental pollutants, induce toxicity that exacerbates 
effects and ultimately leads to detrimental consequences. These results imply that there 
is a necessity to incorporate other stimuli present in the gut, such as microbial 
components and inflammatory cytokines, when investigating effects on IEC health and 
ultimately intestinal barrier integrity as this represents a more holistic approach that 
more closely mimics the gut environment. In addition. Furthermore, these results 
suggest that organoids can provide information into the development of intestinal stem 
cells in gut disorders and diseases as they present us with an ability to monitor and 
track the differentiation of stem cell into mature functional lineages that eventually 
develop to form the intestinal barrier. 
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